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Abstract
Effects of Localized EphB2 Stimuation on Dendritic Filopodia of
Hippocmampal Neurons
Clifford Locke, Ph.D.
University of Connecticut, 2018

Dendritic filopodia are thin, dynamic protrusions of developing neurons that are
thought to search the area surrounding dendrites for pre-synaptic axons. Upon contact
with axons, they are believed to transform into the mature glutamatergic post-synaptic
compartments known as dendritic spines. Through synaptic plasticity, dendritic spines
are suggested to play crucial roles in learning and memory formation.

While

glutamatergic activity is a major stimulus of dendritic spine formation, cell-cell
recognition receptors also play significant roles.
Eph receptors are receptor tyrosine kinases that act as cell-cell contact receptors
through binding their membrane-bound ephrin ligands. They are classified into EphA
and EphB subtypes based on their preferential binding to either ephrinA or ephrinB
ligands. EphB1, EphB2, and EphB3 are collectively necessary for dendritic spine
formation in vivo. They are thought to be activated at axo-dendritic contacts and trigger
direct changes in actin polymerization that drive the transition from filopodia to spines.
While the relevant signaling pathways have been extensively studied, how EphB
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signaling changes the motility and morphology of dendritic filopodia to form dendritic
spines remains poorly understood.
To facilitate real-time monitoring of dendritic filopodia following EphB
stimulation, a photoactivatable EphB2, optoEphB2, was developed. Since Eph receptor
clustering is necessary for efficient downstream signaling, optoEphB2 employs the blue
light-induced clustering of Cryptochrome 2. Photoactivation of optoEphB2 resulted in
rapid tyrosine phosphorylation and signaling to SH2 domain proteins that are known to
act downstream of EphB2. In fibroblasts and hippocampal growth cones, optoEphB2
activation resulted in collapse of protrusive structures, consistent with previous findings
for EphB signaling.
Surprisingly, localized activation of EphB2 at dendritic filopodia promoted
filopodia branching and plasma membrane expansion. Activation along the dendritic
shaft led to formation of new filopodial protrusions in an Arg- and Arp2/3-dependent
manner. In addition, local phosphatidylinositol(3,4,5)-triphosphate (PIP3) accumulation
via phosphoinositide 3-kinase (PI3K) activation was necessary for protrusion formation
and marked a key difference between dendrites and fibroblasts. These results provided
new insights into the role of EphBs in dendritic filopodia, suggesting that they may
increase filopodia density near sites of axo-dendritic contact. Differential regulation of
PIP3 synthesis may represent an important underlying mechanism of the cell contextdependence that characterizes Eph receptor signaling.
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CHAPTER I: Introduction
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Motivation
Dendritic spines are the mushroom-shaped protrusions of neuronal dendrites that
comprise most post-synaptic terminals of excitatory synapses in the central nervous
system (CNS). Dendritic spines are supported by an actin cytoskeleton and contain a
bulbous head that is connected to the dendritic shaft by a thin neck. This architecture
allows for the compartmentalization of post-synaptic proteins and electrical activity1,2.
Dendritic spines are believed to play important roles in learning and memory formation
in humans, and their numbers and morphology are tightly regulated throughout
development. Defects in dendritic spine formation, resulting in abnormal spine density or
morphology, have been described in a number of developmental disorders3.
Many studies have suggested that dendritic spines derive from thin, dynamic
protrusions known as dendritic filopodia1,4.

The first study to suggest this model

examined dendritic filopodia in cultured hippocampal neurons. It was demonstrated that
dynamic filopodia formed stable contacts with axons and that, following the first week in
vitro, the density of dendritic filopodia decreased while that of dendritic spines
increased4. Later electron microscopy studies of rat hippocampal slices showed synaptic
vesicles, which contain neurotransmitters, near sites of contact between filopodia and
axons5. It is thus thought that dendritic filopodia are dynamic protrusions that seek out
axons, stabilize upon contact with them, and subsequently develop into post-synaptic
dendritic spines.

Dendritic spines may then undergo maturation and strengthening,

marked by growth of the spine head, or may be lost. This dynamic nature is termed
synaptic plasticity, while loss is often referred to as synaptic pruning, and these processes
are thought to contribute to memory formation or loss6.
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Changes in the actin cytoskeleton drive most aspects of dendritic spine formation
from dendritic filopodia and subsequent plasticity7. Changing the architecture of actin is
necessary to form and enlarge the spine head and organize post-synaptic proteins, such as
neurotransmitter receptors and important scaffolds. Signaling pathways that ultimately
converge on the actin cytoskeleton in these contexts are known to originate from the
actions of glutamate, the major excitatory neurotransmitter in the CNS. Glutamate binds
post-synaptic ionotropic receptors, triggering an influx of extracellular calcium.
Calcium-sensitive proteins may then transmit signals to the cytoskeleton. Generally, the
result of repeated glutamatergic stimulation is spine head enlargement and recruitment of
additional glutamate receptors, which strengthens the synapse6.
While glutamate is the primary director of dendritic spine maturation, filopodia
have been shown to form stable contacts with axons in the absence of glutamatergic
activity8. There is, therefore, a major role for cell-cell recognition molecules in the
formation of dendritic spines9. An important family of cell-cell contact receptors that
drive the formation of dendritic spines is the Eph receptor family. Briefly, Eph receptors
are members of the largest receptor tyrosine kinase (RTK) family in mammals, and are
sub-classified into EphA (EphA1-A8, A10) and EphB (EphB1-B4, B6) subtypes. They
become activated at cell-cell contacts upon binding their membrane-bound ligands, the
ephrins, and subsequent receptor clustering10,11.

Their primary function is to guide

migrating cells during developmental processes, and they therefore play important roles
in gastrulation, cell positioning, tissue patterning, and organogenesis.
Prior studies have suggested that EphB signaling promotes the formation of
dendritic spines in hippocampal neurons12. These conclusions were drawn from an initial
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observation that overexpression of kinase-dead EphB2 in cultured rat hippocampal
neurons impaired dendritic spine development13.

Follow-up work examined the

morphology of dendritic protrusions in cultured mouse hippocampal neurons and brain
slices when various combinations of EphB1, EphB2, and EphB3 were genetically
knocked out.

It was found that knocking out two of these three EphB subtypes

significantly reduced dendritic spine density in vitro, and knocking out all three of
EphB1-B3 reduced spine density in vivo14. Additionally, many studies used ephrinB
ligands to stimulate EphB signaling in cultured hippocampal neurons and observed
increased dendritic spine density and spine head size15. These studies strongly suggested
that signaling from EphB receptors was necessary for both proper spine formation and
maturation, and that EphB1-B3 were at least partially redundant in these processes.
To understand the effect of EphB signaling on dendritic spine formation, a logical
step is to understand how they affect dendritic spine precursor structures, dendritic
filopodia. Indeed, by knocking down EphB2 in cultured hippocampal neurons in a timespecific fashion, it was found that the effect of EphB2 on spine formation was confined to
the second week in vitro, when filopodia are most abundant16. Overexpression of EphB2
rescued dendritic spine loss in EphB1-B3 triple-knockout neurons only during this time
frame as well16. This suggested that EphB signaling must have specific effects on
dendritic filopodia that promote their transition to dendritic spines.
Interestingly, neurons cultured from EphB1-EphB3 triple-knockout mice
displayed normal filopodia density early in development16, suggesting that EphB
signaling did not affect filopodia formation. However, decreased filopodia motility was
observed versus wild-type neurons16. This would suggest that basal EphB activity is
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important to maintain the motility of dendritic filopodia, a property that is important for
their axon-searching function. Other studies examined the effects of EphB signaling by
stimulating cultured neurons with ephrinB ligands.

In addition to increasing spine

formation, ligand stimulation also resulted in an overall increase in dendritic protrusion
density, including spines and filopodia, and filopodia shortening14,17. These outputs are
consistent with a role for EphB signaling in increasing the number of dendritic spines.
Filopodia shortening is expected during dendritic spine morphogenesis, immediately
following contact formation, and increasing protrusion density would necessarily lead to
more potential contact sites.
The results discussed above are consistent with an increase in dendritic spine
density following activation of EphB signaling by ephrinB binding, but do not fully
address how this signaling contributes to the transition from filopodia to spines.
Genetically knocking out EphB1-B3 eliminates their basal activities, but does not fully
address how their signaling affects filopodia motility or morphology at axo-dendritic
contacts, where EphBs are presumably engaged by their ligands. Knocking out EphB
isoforms may also affect the expression of other proteins, and the observed effects may
have been the result of an abnormal pattern of protein expression. Since ephrinB ligand
treatment increased protrusion density, one may expect that EphB1-B3 triple-knockout
would reduce protrusion density, though no effect was observed. Protrusion density is
inherently governed by both the rate of protrusion formation and loss. It is unclear if the
increased protrusion density was secondary to increased formation of filopodia, some of
which may have become spines, or stabilization of existing protrusions.

Increased

protrusion formation would not be supported by the separate finding of filopodia
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shortening upon EphB stimulation; elongation would be expected to promote protrusion
formation. Additionally, bath application of ligands does not fully reflect what may
happen to single filopodia when EphBs are activated at individual contacts.
Therefore, the effects of EphB signaling on the motility and morphology of
dendritic filopodia remain poorly understood. This biological question is the primary
motivation behind this thesis, and answering it will improve our understanding of how
EphBs transform filopodia into spines. A number of hypotheses can be made. Since
EphBs are activated at cell-cell contacts, and filopodia must stabilize upon contact with
axons to become spines, EphB signaling may initiate spine morphogenesis by directing
contact stabilization. One would expect, then, reduced filopodia motility in response to
EphB stimulation. EphB signaling at contacts along the dendritic shaft is also possible,
since EphBs are expressed on the dendritic shaft18. EphBs may direct the formation of
protrusions from the dendritic shaft, which may then become spines.

The known

interactions between EphBs and glutamate receptors19,20 may suggest that EphBs have no
direct effect on the actin cytoskeleton. Rather, their function may be to recruit glutamate
receptors to filopodia, whose activity via calcium influx may then independently alter the
actin cytoskeleton to direct the transition to mature dendritic spines.
Observing the effect of EphB signaling on the morphology and motility of
dendritic filopodia would be facilitated by spatial and temporal control over EphB
signaling. This would ensure that signaling originates from dendritic filopodia, which
would better simulate the scenario of filopodia coming into contact with axons. Thus, the
aims of this thesis were two-pronged: to develop a technique to spatially and temporally
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stimulate EphB signaling, and then dynamically monitor responses of dendritic filopodia
to localized stimulation.
This chapter provides a detailed overview of the topics covered in this thesis. I
will begin with a discussion of Ephs and ephrins, covering the structural and molecular
basis behind their signaling and functional consequences. A discussion of optogenetics
and, specifically, the blue light-sensitive plant photoreceptor Cryptochrome 2 follows.
Dendritic spine formation and the role of Eph receptors in this process will then be
discussed.

I will then give a summary of experimental results and the primary

conclusions of this thesis, which will be discussed in detail in Chapters II and III.

Eph Receptors and Ephrins
Erythropoietin-producing human hepatocellular carcinoma (Eph) receptors
comprise the largest family of receptor tyrosine kinases (RTKs) in humans10. As their
name suggests, the first Eph receptors were identified in 1987 as candidate oncogenes in
an erythropoietin-producing hepatocellular carcinoma cell line21. Since then, nine EphA
(EphA1-A8, A10) and five EphB (EphB1-B4, B6) receptors have been characterized in
humans10. This classification into A and B subtypes is based on the receptors’ relative
binding affinities for the five glycosyl phosphatidylinositol (GPI)-linked ephrinA
(ephrinA1-A5) or three transmembrane ephrinB (ephrinB1-B3) ligands. It should be
noted, however, that these binding interactions display some promiscuity. For instance,
EphA4 binds ephrinBs, and ephrinA5 is capable of binding EphBs22,23.
Both Ephs and ephrins are membrane-bound and are therefore activated at cellcell contacts. Uniquely, both the receptors and ligands transmit downstream signals,
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resulting in so-called “bidirectional” signaling24.

Colloquially, signaling from Eph

receptors is termed “forward” signaling, and “reverse” signaling emanates from ephrins.
Eph receptors and ephrins transduce cell-cell contacts into changes in cell migration,
proliferation, and survival.

They are crucial to normal cell positioning and tissue

patterning during developmental processes, such as organogenesis, tissue boundary
formation, topographic mapping, axon guidance, and synaptogenesis10. As suggested by
their discovery, Eph receptors are also important in cancer biology and are known to
function as tumor suppressors and promoters, depending on the Eph receptor subtype and
type of cancer24.
The structure, function, and signaling pathways that define Eph receptors mirror
those of other members of the RTK family.

To fully appreciate their biology, an

overview of RTKs is given. Specific features of Eph receptors will follow.

Receptor Tyrosine Kinases
Receptor tyrosine kinases (RTKs) are unique transmembrane receptors that
regulate critical cell functions, including cell proliferation, differentiation, migration, and
survival25. A large number of RTK families exist and many, for example, the fibroblast
growth factor receptor (FGFR) and epidermal growth factor receptor (EGFR) families,
respond to growth factors. RTKs are crucial in developmental processes, and mutations
or other dysfunctions of RTKs are associated with numerous developmental and
neoplastic disease states.

For example, many breast cancers are marked by

overexpression of the EGFR family member ErbB226, and Kallman Syndrome27, a
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developmental disorder affecting the normal development of cranio-facial structures, is
caused by a mutation in FGFR1.
Typically, RTKs are composed of extracellular domains that consist of a ligandbinding domain and other unique motifs, a transmembrane domain, and intracellular
domains with catalytically-active tyrosine kinases27. Most RTK intracellular domains
assume an auto-inhibitory conformation in the inactive state. Typically, ligand-induced
dimerization results in auto-phosphorylation events that relieve this auto-inhibitory
configuration27. Intracellular tyrosine kinase domains may then access their substrates,
which include tyrosine residues on the receptors themselves that are phosphorylated in
trans and other downstream signaling molecules.
Phosphotyrosines on the RTKs and their substrates serve as docking sites for
proteins containing Src homology-2 (SH2) and phosphotyrosine binding (PTB)
domains28.

The various SH2 and PTB domains selectively bind different

phosphopeptides28–30, which allows many RTKs to display specificity for particular
effectors.

These SH2/PTB domain-containing proteins may serve as adaptors or

scaffolds to organize large macromolecular complexes, such as focal adhesions, and
others contain enzymatic properties. Some, such as Src, Abl, and Arg, are tyrosine
kinases themselves, known as non-receptor tyrosine kinases (NRTKs)28. Interactions
other than SH2/PTB domain-phosphotyrosine interactions, such as PDZ (PSD-95, Discs
large, Zona occludens-1) domain binding, Src homology-3 (SH3) domain binding to
polyproline motifs, and plasma membrane lipid alterations, are also important in RTK
signaling pathways. In many cases, these occur as secondary interactions with SH2/PTB
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domain proteins that stabilize phosphotyrosine-mediated interactions27.

These other

interactions also diversify the signaling complexes formed by SH2 domain adaptors.
Downstream signals from RTKs affect the cytoskeleton and expression of genes
that regulate cell survival, metabolism, cell cycle progression, and differentiation 31.
Major downstream signaling pathways include the Rho family of GTPases, the
Ras/MAPK signaling cascade, and phosphoinositide 3-kinase (PI3K) signaling. Some
receptors do not themselves contain tyrosine kinase activity, but resemble RTKs by
associating with the Janus family of NRTKs (JAK), which activate the signal transducer
and activator of transcription (STAT) family of transcription factors25. The Rho and Ras
GTPases and PI3K signaling are most relevant to this thesis and are discussed in further
detail below.
Rho and Ras GTPases are signaling proteins with intrinsic GTPase activity that
are active when GTP-bound and inactive when GDP-bound. Relevant to this discussion,
the Rho GTPase family refers to the GTPases Rac1, Cdc42, and RhoA32. The Ras
GTPases consist of a variety of members, with emphasis here on the canonical H-Ras, NRas, and K-Ras isoforms, collectively referred to as “Ras” in many publications, and the
Ras-related (R-Ras) proteins33.

RTKs typically regulate their activity by signaling

guanine nucleotide exchange factors (GEFs), which activate GTPases by facilitating
replacement of GDP with GTP, and GTPase-activating proteins (GAPs), which inhibit
GTPase signaling activities by facilitating hydrolysis of GTP to GDP27,31,32.
Most canonical Ras isoforms signal the Raf family of kinases, which then activate
the mitogen-activated protein kinase (MAPK) cascade.

This cascade is a string of

kinases, beginning with activation of the Raf kinases, which then phosphorylate and
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activate MAPK kinase (MEK), which then activates MAPK, also known as ERK.
Phosphorylated ERK isoforms may translocate to the nucleus, where they increase the
transcription of genes that promote cell growth and survival31. Both canonical Ras and
R-Ras proteins are capable of activating PI3K. However, R-Ras proteins typically do not
interact with Raf kinases and activate the MAPK cascade34.

In addition to gene

regulation, canonical Ras and R-Ras family members can activate or inhibit signaling of
integrins, which are transmembrane receptors that bind extracellular matrix (ECM)
proteins to influence cell adhesion and migration35.
The Rho GTPases Rac1, Cdc42, and RhoA affect cell migration and motility by
altering actin polymerization32. RhoA is generally thought to direct cell retraction by
signaling through Rho-associated protein kinase (ROCK) to activate myosin-based
contractile forces. It may also signal the mDia family of formins, which increase actin
polymerization. Rac1 and Cdc42 signal WAVE and N-WASP, respectively, which may
activate the Arp2/3 complex and nucleate branched actin filaments. They also signal
through p21-associated kinase (PAK) to inhibit acto-myosin contractile forces. They,
therefore, mediate the formation of cellular protrusions. Lamellipodia are formed by
inducing broad plasma membrane extensions through nucleation of a highly-branched
actin network. Filopodia are formed by elongating parallel actin bundles32. Tight spatial
and temporal regulation of these Rho GTPases are necessary for proper cell motility,
migration, and polarity.
Phosphoinositie-3-kinases (PI3K, Fig. 1.1) comprise a family of lipid kinases that
phosphorylate the 3-hydroxyl group of inositol ring of phosphatidylinositol family lipids
on the inner leaflet of the plasma membrane. Of special interest in RTK signaling are the
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class I PI3Ks, which are composed of regulatory and catalytic subunits. Some regulatory
subunits contain SH2 domains that bind phosphotyrosines on RTKs. These subunits
derive from three genes: p85, p55, and p50 are splice isoforms of the PIK3R1 gene,
p85 is the product of the PIK3R2 gene, and p55 is the product of the PIK3R3 gene36.
Each regulatory subunit contains two SH2 domains whose inter-SH2 domain binds the
catalytic subunits p110, p110, and p110. The regulatory subunits hold the catalytic
subunits in an inactive conformation, and recruitment to phosphotyrosines in RTK
signaling complexes is one mechanism to relieve this inhibition and bring the catalytic
subunits to their plasma membrane substrates36.

In addition to regulatory subunit

recruitment, Ras GTPases also activate class I PI3K activity through binding the catalytic
subunit37–39.
Class

I

PI3Ks

phosphorylate

phosphatidylinositol(4,5)-bisphosphate

(PIP2)

the
to

plasma
form

membrane

lipid

phosphatidylinositol(3,4,5)-

triphosphate (PIP3)36. These lipids serve crucial roles in regulating actin polymerization
and gene expression. PIP3 and, in some cases, PIP2, can interact with lipid-binding
domains, such as the pleckstrin homology (PH) domain, in a variety of proteins to
activate their signaling. Notable examples include Akt/protein kinase B, many of the
same adaptors that signal in RTK signaling complexes, and GEFs and GAPs that activate
and inhibit Ras and Rho family GTPases36. Akt is a serine/threonine kinase that promotes
cell survival.

Its signaling promotes the expression of anti-apoptotic proteins and

degradation of pro-apoptotic proteins. Akt also increases protein translation by signaling
the mammalian target of rapamycin (mTOR)40. The PH domains of many GEFs and
GAPs have been shown to bind PIP3 and, in some cases, this binding enhances their
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activation36. Subsequent changes in Rho GTPase activity affect actin polymerization and
cell migration32, as outlined previously.
As previously stated, Eph receptors are very similar to other RTKs in their
signaling activation and properties. They do, however, display many unique features that
allow them to serve specific functions, such as their role in contact repulsion secondary to
their activation at cell-cell contacts. Details are discussed for the remainder of this
section.

Structural Basis of Eph Receptor Clustering and Forward Signaling
Like other RTKs, Eph receptors undergo autophosphorylation upon ligand
binding and transmit downstream signals through tyrosine phosphorylation of substrates
and binding other adaptors.

As previously discussed, Eph receptor ligands are

membrane-bound and capable of transmitting downstream signals. Another unique
feature of Eph receptors is the requirement of receptor clustering for efficient
downstream signaling11 (Fig. 1.2). This was first demonstrated by Davis et al.41, who
showed that only membrane-bound or antibody-clustered ephrin ligands were sufficient
to activate Eph receptors. Another study showed that dimerized soluble ligands were
sufficient to induce Eph receptor autophosphorylation, but larger aggregates were
necessary for downstream effector recruitment and to observe expected changes in cell
adhesion and migration42. Studies that examined the effect of cluster size, by either
antibody-mediated soluble ligand clustering42 or chemical cross-linking43, demonstrated
that Eph receptor aggregates larger than dimers represent the minimum signaling unit
required for Eph receptor signaling.

It was also suggested larger clusters transmit
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stronger signals43. Studies have shown that different types of Eph receptors, including
both EphAs and EphBs, may co-exist in the same cluster, and signaling outputs depend
on the relative amounts of each receptor present11,44. Signaling pathways and functional
consequences downstream of Eph receptor signaling are, thus, highly complex. The
structural basis of ligand-receptor binding, Eph receptor activation, and clustering have
been analyzed by a variety of structural studies.
This section will focus primarily on forward signaling, but a brief overview of
ephrin reverse signaling is provided here.

Both ephrinBs and ephrinAs consist of

extracellular receptor-binding domains (RBDs, Fig. 1.2) and bind Ephs with high affinity.
A surface plasmon resonance study showed that single ephrin-Eph interactions bind with
a dissociation constant on the order of tens of nM45. EphrinBs are transmembrane
proteins with unstructured intracellular domains that contain C-terminal PDZ binding
motifs and numerous conserved tyrosine residues that are phosphorylated upon activation
(Fig. 1.2). It is thought that tyrosine phosphorylation of ephrinBs is carried out by other
tyrosine kinases, especially the Src family46. EphrinBs serve many of the same functions
as Eph receptors through binding SH2 domain adaptors, such as Grb4, and PDZ domain
proteins47. EphrinAs are GPI-linked and entirely extracellular. They associate with coreceptors to transmit downstream signals. For instance, ephrinAs are known to bind and
signal through the neurotrophin receptor p75 in retinal axons to direct growth cone
steering during axon guidance48.
The general structure of Eph receptors is shown in Figure 1.2. In the extracellular
region, EphA and EphB receptors contain an N-terminal ligand-binding domain (LBD),
followed by a cysteine-rich domain (CRD) that contains sushi and EGF-like motifs, and
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two fibronectin-type III repeats10. The juxtamembrane (JM) region immediately Cterminal to the transmembrane domain contains conserved phosphotyrosine motifs that
relieve intracellular autoinhibition of the kinase domain upon phosphorylation49. They
are also major binding sites for SH2 domain-containing proteins, though many sites have
been identified throughout the intracellular domain50–53. The JM region is followed by
the kinase domain, and the C-terminus of Eph receptors consists of a sterile-alpha motif
(SAM) and a PDZ-binding motif (PBM).
Eph-ephrin signaling is believed to initiate from heterotetramers consisting of two
ephrins and two Ephs. The structure of these heterotetramers was determined by X-ray
crystallography of purified complexes containing the ephrinB2 ECD and the EphB2
LBD54. The heterotetramers were formed by multivalent interactions that allowed each
ephrin to simultaneously bind both Eph receptors, and vice versa, through two interfaces
in the Eph LBD and ephrin ECD. One of these interfaces was, of course, composed of
the Eph receptor ligand-binding pocket and the ephrin receptor binding domain, and the
other was located outside of these regions. Other structural studies observed similar
interactions55,56. It is thought that these heterotetramers then arrange into higher-order
clusters. Further crystallography studies with larger portions of the Eph receptors’ ECDs
predicted residues in the CRD and LBD that mediate cis interactions between receptors
on the same cell surface55,56. Thus, Ephs may initially bind ephrins in the heterotetramer
arrangement and then use the CRD- and LBD-mediated interactions to expand into
clusters.
Interestingly, the LBD- and CRD-mediated receptor-receptor interactions were
observed in the absence of ligand binding. Overexpression of Eph receptors induced
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ligand-independent receptor autophosphorylation that was abrogated by select point
mutations in the CRD56. These results suggested that clustering is an intrinsic property of
the receptors themselves and may only depend on the concentration of receptors on the
cell surface.

It is possible that ephrin ligands only serve to increase the local

concentration of receptors, or orient the receptors in an appropriate conformation, to
promote clustering. This idea is supported by the observation that the Eph receptor ECD
undergoes

little

conformational

change

after

ligand

binding56.

Additionally,

immunofluorescence studies have shown that ephrins may exist in plasma membrane
microdomains, and some studies suggest that ephrins associate with lipid rafts57,58. These
results suggest that ephrins are closely-packed to begin with. In fact, ephrin receptorbinding domains have been shown to homo-dimerize54. Since Eph receptors can selfassociate, it is also possible that both ephrins and Eph receptors exist in an equilibrium
between monomers and dimers, and that ephrin dimers can cross-link Eph receptor
dimers to result in clustering arrays.
Other domains of Eph receptors, and their effectors, have been shown to modulate
Eph receptor clustering. The N-terminal fibronectin type III (FNIII) repeat was shown to
contain a receptor-receptor binding interface in EphAs55. Crystal structures of the SAM
domain showed the potential for dimerization59, suggesting a role for intracellular
regulation of Eph receptor dimerization or clustering. Additionally, studies suggest that
interactions between Eph receptors and PDZ domain proteins may promote or reduce Eph
receptor clustering and activation. Overexpression of the PDZ domain protein PICK1
with EphB2 in COS7 cells induced EphB2 clustering60. However, deletion of the SAM
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and PBM of EphB2 was independently shown to enhance EphB2 clustering and
activation43.
Eph receptor clustering results in complex functional consequences. Ephs of
different types, including those of different classes, may co-exist in the same signaling
complexes. This was demonstrated by co-immunoprecipitation of, and co-localization of
clusters containing, EphB2 and EphA3 receptors in HEK293 cells44. Treatment with
ephrinA or ephrinB ligands caused phosphorylation of both EphB2 and EphA3,
suggesting cross-phosphorylation44. Some data suggest that ephrin stimulation of cells
often results in functional outputs that represent a composite of all Eph receptors
expressed, and are dependent on the relative expression level of each receptor subtype11.
Competition between Eph receptors on the same cell has been shown. Astin et al.
(2010)61 used ephrinA5- and ephrinB2-coated microbeads to stimulate Eph signaling in a
prostate cancer cell line. While ephrinA5 caused cell repulsion, ephrinB2 promoted cell
migration, and was able to reverse cell repulsion caused by ephrinA5 when both ligands
were present on the same beads61.
Given the promiscuity of ligand binding and the heterogeneity of Eph receptor
clusters, canonical signaling pathways for each receptor subtype remain elusive10.
Adding to this complexity is the cell context-dependence of Eph receptor signaling. An
individual Eph receptor subtype may trigger diametrically-opposed responses in different
cell types, and the mechanism behind this phenomenon is poorly understood.

The

following section will outline the regulation, major downstream pathways, and functional
consequences of Eph receptor signaling.
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Functions and Mechanisms of Eph Receptor Signaling
Eph receptors signal the actin cytoskeleton and affect protein expression to
regulate cell adhesion, migration, and survival. Eph-ephrin signaling cascades typically
mediate repulsive cues, and spatial gradients of Eph and ephrin expression across tissues
are regulated over space and time to ensure that cells or cellular processes migrate to the
right place at the right time10.

This interplay between repulsive cues and spatial

regulation has been well-studied in topographic mapping of the central nervous system by
Eph receptor-mediated axon guidance62–64.

EphA-expressing growth cones in the

retinotectal system, for example, were shown to be directed from areas of high ephrinA
expression to areas of low expression. This process ensures that axons from a given
visual field in the retina reach their appropriate target neurons in the superior colliculus 64.
As another example, Eph/ephrin signaling is important to establish boundaries between
arterial and venous vascular structures65.
Eph and ephrin signaling outputs are highly heterogeneous and cell contextdependent, and Eph receptor signaling sometimes functions to promote cell migration and
cell-cell adhesion. For example, EphB4 promotes tumor growth in some breast and lung
cancers66,67, but was shown to have tumor-suppressing effects in colorectal cancer68.
EphrinA1/EphA2 forward signaling is pro-angiogenic by increasing endothelial cell
migration69, but inhibits the migration of prostate cancer and glioma cells70. The cause of
this cell context-dependence is unclear. Some studies of Eph receptor signaling to
specific downstream effectors have addressed this question, and will be discussed below.
Functional consequences of Eph receptor signaling are primarily mediated by the
Rho GTPases Rac1, Cdc42, and RhoA, the Ras family of GTPases, and PI3K10. The
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following sections will focus on how Eph/ephrin forward signaling affects the
aforementioned pathways to confer cell-cell repulsion or adhesion, and cell survival or
death, with illustrative examples.

The nature of cell context-dependence will be

discussed where appropriate. I will focus on EphB signaling pathways as illustrative
examples over EphAs due to the nature of my thesis work.

Ras Family GTPases
Unlike many other RTKs, Eph receptors have been shown to induce cell process
retraction and reduce cell adhesion and survival by inhibiting R-Ras and Ras/MAPK
signaling47. In general, published literature on this topic does not differentiate between
the canonical Ras isoforms H-Ras, K-Ras, and N-Ras, and, as such, the connotation
“Ras” will indicate the canonical isoforms collectively and the term “R-Ras” will refer
specifically to the R-Ras proteins. A common mechanism among Eph receptors to inhibit
Ras and R-Ras is activation of p120RasGAP through binding its SH2 domain47,71,72.
EphB2 induced repulsive responses in COS-1 cells and neurite retraction in EphB2expressing neuroblastoma (NG-108) cells by activating p120RasGAP50,71,72. Since the
Ras/MAPK pathway acts downstream of many RTKs, Eph receptor signaling can
modulate outputs from other RTKs. For example, Eph receptor signaling was shown to
inhibit MAPK activation by the platelet-derived growth factor receptor (PDGFR) and the
vascular endothelial growth factor receptor (VEGFR), among others73.
EphB2 has also been shown to reduce cell adhesion by inhibiting R-Ras through
p120RasGAP or direct tyrosine phosphorylation72,74. Inhibition of R-Ras by EphB2 was
shown to reduce adhesion of cells to substrates containing integrin ligands74, suggesting
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R-Ras inhibition as a means for Eph receptors to inhibit integrin-mediated adhesion. This
aspect of EphB2/R-Ras signaling may be relevant to cancer biology. A study of glioma
cell migration revealed that EphB2-mediated R-Ras tyrosine phosphorylation was
associated with reduced adhesion and increased invasion75.

This study, however,

characterized R-Ras tyrosine phosphorylation as activating, though there was no data to
show an increase in GTP-bound R-Ras.
In some contexts, Eph receptors may activate Ras/MAPK signaling. Both EphA2
and EphB1 increased MAPK signaling through binding the SH2 domain adaptor Grb2
and members of the Shc family of SH2 domain adaptors, albeit with different functional
outputs- EphA2-mediated signaling decreased ECM attachments, while EphB1 signaling
promoted chemotaxis.

In both cases, MAPK activation and Grb2 recruitment were

dependent on engaging Shc-family adaptors76,77. Grb2 is known to associate with the
Ras-GEF SOS, and presumably this mechanism is responsible for MAPK activation76.
Some studies have explored the mechanism underlying this cell contextdependence. Signaling from other RTKs may influence the effect of Eph receptors on
Ras. For example, increased FGFR signaling was shown to switch the effect of EphB2
from activation to inhibition of MAPK signaling78. Differences in downstream effectors
have also been suggested to play a role. For example, a study of EphB4 signaling in
human umbilical vein endothelial cells found that EphB4 inhibited Ras/MAPK signaling
by engaging p120RasGAP. However, EphB4 increased Ras activity in MCF7 breast
cancer cells in a manner that depended on

protein phosphatase 2 (PP2A)79.

The

respective effects on Ras activity were abrogated by knocking down p120RasGAP or
PP2A.
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Eph receptors may also activate or inhibit the Ras-related GTPase Rap1 in a cell
context-dependent manner.

Briefly, Rap1 signaling overlaps with the other Ras

superfamily GTPases, but is uniquely involved in regulating cell-cell junctions, largely
through its effector, afadin80. In fact, afadin can bind Eph receptors as well81. Eph
receptors typically activate Rap through the GEF C3G, which associates with the SH2
adaptors Crk and CrkL10,82. EphB signaling was shown to activate Rap through direct
recruitment of Crk to increase membrane ruffling and cell adhesions in endothelial
cells83. In some contexts, however, Crk and CrkII are inhibited by recruitment of the
NRTK Abl to Eph receptors, which deactivates Crk by phosphorylation and disrupts its
effector binding67,82. In neurons, EphA4 inhibits Rap through PBM-mediated recruitment
of the Rap-GAP SPAR84.

Rho Family GTPases
Eph receptors may also initiate cell-cell repulsion by activation of RhoA and
inhibition of Rac1 and Cdc42, resulting in acto-myosin contractility to inhibit protrusive
structures and cell migration73,85. EphAs are known to induce growth cone collapse, alter
vascular smooth muscle contractility, and reduce T cell chemotaxis by activating RhoA
through the ephexin family of RhoGEFs86,87. In growth cone collapse, transient Rac1
inhibition is accomplished through recruitment of the Rac1 GAP 2-chimaerin through
binding its SH2 domain88. Both ephexin and 2-chimaerin are tyrosine phosphorylated
by the Src family kinases in this context88,89. However, growth cone collapse requires
Rac1 activity to endocytose the Eph/ephrin complexes, and recruitment of the GEF Vav2
to EphA4 was suggested to play a role90. EphBs are also known to activate RhoA to
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induce growth cone collapse91,92, synaptogenesis17, and increase migration of invasive
melanoma cells93, though the specific GEFs involved are unknown.
Eph receptors are also known to promote cellular protrusions and cell migration
by favoring Rac1/Cdc42 signaling over RhoA in some contexts. In addition to mediating
endocytosis during growth cone collapse, Vav-mediated Rac1 activation is also important
to induce endothelial cell migration in EphA-dependent angiogenesis94. Another study
showed PI3K upstream of Rac1 in this process, and Cdc42 activation was observed as
well69. In glioma cells, EphA4 overexpression was associated with increased migration
and proliferation due to Rac1 and Cdc42 activation95, though EphA4 showed interactions
with FGFR in this context, and the effects may have been indirect. EphB signaling
increased membrane ruffling and cell adhesions in endothelial cells by activating Rac1
via the GEF DOCK1 downstream of Crk83. EphBs, as discussed in a later section, also
interact with the Rac-GEFs kalirin-7 and Tiam1 and the Cdc42-GEF intersectin to
promote dendritic spine formation in hippocampal neurons12. An interaction between
EphB2 and the Rac-GEF -Pix96, mediated by the adaptor protein Nck, has been
demonstrated and also suggests Rac1 and Cdc42 activation by EphBs. In prostate cancer
cells, EphAs and EphBs were shown to differentially regulate contact inhibition of
locomotion through selective Rho GTPase activation61. EphAs induced cell process
retraction through RhoA, and EphBs increased cell migration through Cdc42.

Phosphoinositide 3-kinase
Eph receptors also display highly context-dependent regulation of class I PI3K
activity to promote or suppress cell survival and migration. The general functions of Eph
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receptors to mediate repulsive cues and inhibit Ras are consistent with inhibition of PI3K
signaling.

EphB2, for example, was shown to inhibit PI3K signaling pathways in

multiple contexts. EphrinB1 stimulation of EphB2 and EphB4 in medulloblastoma cells
decreased cell adhesion and levels of phosphorylated mTOR97, indicating reduced
PI3K/Akt signaling.

A recent study of chemotaxis in MTLn3 breast cancer cells

overexpressing EGFR showed down-regulation of PI3K activity by EphB2 that opposed
EGFR-mediated chemotaxis98. However, EphB signaling is known to activate PI3K in
other contexts.

Intrathecal and peripheral injections of ephrinB1-Fc in living mice

induced hyperalgesia that was dependent on increased expression and activity of PI3K
catalytic subunits99,100. EphB2-mediated activation of -Pix through PI3K was
demonstrated in 293T cells96.

Additionally, EphB2 was shown to inhibit Tau

phosphorylation, which promotes the pathogenesis of Alzheimer’s Disease, in mature
hippocampal neurons by activating PI3K signaling101.
Little is known about how PI3K is activated or inhibited downstream of EphBs.
Inhibition may be mediated by inhibition of Ras family GTPases, which are known PI3K
activators37. Activation may occur through recruitment of regulatory subunits, suggested
by an in vitro interaction reported between phosphorylated EphB2 and the SH2 domain
of p85 ( or  not specified)50. A study of EphB2 signaling in colonic crypt cells in vivo
showed that EphB2 promotes PI3K-dependent cell migration in an EphB2 kinaseindependent manner102.

Kinase-independent signaling would suggest a mechanism

independent of SH2 binding and, perhaps, constitutive association with a PI3K activator.
Other Eph receptors present a similarly complex story. EphA2, for example, was
shown to promote vascular endothelial cell migration through PI3K following ephrinA1
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stimulation69. Similar treatment of glioma and prostate cancer cells, however, caused
reduced cell migration secondary to PI3K inhibition70. In the same study, overexpression
of EphA2 was shown to increase migration in these cells in a ligand-independent manner,
suggesting PI3K activation in the absence of kinase activity70.

These results are

strikingly similar to the aforementioned observations of kinase-independent PI3K
activation by EphB2 in colonic crypts102, raising the possibility of a common mechanism.
However, PI3K activation is largely thought to occur by regulatory subunit recruitment or
Ras activation, both of which typically require RTK activation.

Abelson family kinases
The Abelson family kinases Abl and Abl2/Arg are non-receptor tyrosine kinases
(NRTKs) that act as regulators of the cell cycle and actin cytoskeleton organization.
Kinase activation is achieved by engagement of their SH2 domains, typically through
binding RTKs, or SH3 domains. Arg is of particular interest because it is enriched in
dendritic spines and is known to maintain dendritic spines in adult mice103. The SH2
domains of Abl and Arg were shown in a yeast-two-hybrid assay to bind the
phosphorylated juxtamembrane tyrosine residues of EphB2.

Their results were

confirmed by in vitro pull-down assays104. This study also demonstrated a positive
feedback loop between EphB2 and Arg, whereby EphB2 phosphorylates Arg, which may
then phosphorylate EphB2104. Interestingly, no follow-up work has been done to study
this interaction further, though some studies have characterized Abl as an important
effector of Eph receptors. Previous sections described Eph receptor-mediated inhibition
of the adaptor Crk through Abl, which inhibited downstream Rho and Rap GTPases. In
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intestinal crypts, EphB signaling promoted proliferation of epithelial cells through Ablmediated activation of cyclinD1, a key regulator of the cell cycle102. Abelson family
kinases also interact with EphA4, as shown by the aforementioned yeast-two-hybrid
study104. This interaction is also of functional significance, because the Abelson family
kinase inhibitor STI571 blocked retinal growth cone collapse downstream of EphA4
activation105.

Catalytically-inactive Eph receptors
Two members of the Eph receptor family, EphB6 and EphA10, are catalyticallyinactive owing to mutations in conserved regions of their tyrosine kinase domains.
Nonetheless, they contain their own signaling activities and contribute to the complexity
and cell context-dependence of Eph receptor signaling106. Studies, primarily of EphB6
signaling, have shown that catalytically-inactive Eph receptors associate with, and are
tyrosine phosphorylated by, catalytically-active Eph receptors and other non-receptor
tyrosine kinases. EphB1 and EphB4 bind and tyrosine phosphorylate EphB6, as do Src
family kinases107–109. EphB6 is thought to be tumor-suppressive, as studies in various
forms of cancer showed an inverse relationship between EphB6 expression levels and
tumor invasiveness, particularly in breast cancer106,110. A mechanistic explanation for
these observations was described in a study that showed competition between EphB6 and
EphB4 in modulating the invasiveness of breast cancer cells. By signaling c-Cbl and Abl
in an EphB4-dependent manner, EphB6 promoted breast cancer cell adhesion to
fibronectin and reduced invasiveness in a Matrigel assay. This opposed the pro-invasive
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effects of EphB4109 and suggested that catalytically-inactive Eph receptors can associate
with other Ephs to antagonize downstream signaling pathways.
Unlike EphB6, EphA10 is thought to act as a tumor promoter. Though the
signaling pathways remain uncharacterized, its expression is up-regulated in multiple
highly-invasive and metastatic cancers. Normally, EphA10 is silenced in most tissues
except for the testes, and it is thought that up-regulation of gene expression in some
cancers may play a role in increasing invasiveness106.

Negative regulation of Eph receptor signaling
The primary mechanisms by which Eph/ephrin signaling is down-regulated are
endocytosis of the receptors, proteolytic cleavage of Eph and ephrin extracellular
domains, and de-phosphorylation of phosphotyrosines47. Receptor internalization by
endocytosis is a typical outcome of RTK signaling. Once internalized, receptors may be
shunted to the endosomal pathway for degradation, or they can be recycled. Eph/ephrin
complexes display trans-endocytosis, in which the Eph- or ephrin-expressing cell
internalizes the entire Eph/ephrin complex. This process depends on Rac1 activity, and
some data suggest that the Vav family of GEFs is specifically responsible for Rac1
activation that leads to trans-endocytosis90,111. The ubiquitin ligase Cbl, which contains
SH2 domains, is also known to bind Eph receptors and contribute to their internalization
and degradation in some contexts47.
In some cases, extracellular proteolytic cleavage of Ephs or ephrins precedes
internalization112.

Members of the matrix metalloproteinase (MMP) family and

ADAM10 (a disintegrin and metalloproteinase 10) have been shown to cleave both Ephs
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and ephrins to down-regulate signaling112. MMPs are secreted or cell membrane-bound
proteases that typically act on ECM or other membrane-bound proteins112. MMP family
members have been shown to cleave members of the EphA and EphB subfamilies, and
cleavage sites identified in EphA2 and EphB2 lie within the FNIII repeat domains92,113.
ADAM family proteases are membrane-bound and known to act on growth factor
receptors, cell adhesion molecules, and other membrane-bound proteins112. One member
of the disintegrin and metalloproteinase (ADAM) family, ADAM10, has been shown to
cleave ephrin ECDs in numerous contexts112. Studies have shown that ADAM10 weakly
associates with Eph receptors, and that this association strengthens with Eph receptor
activation and allows it to cleave ephrin ECDs in trans112.
Proteolytic cleavage and/or internalization of the Eph/ephrin signaling complexes
are thought to be necessary to convey repulsive cues in response to Eph/ephrin
signaling47,92,111,112. A study by Lin et al. (2008)92 showed that retraction of HEK293
cells and growth cone collapse were inhibited by mutating EphB2 to render it resistant to
proteolytic cleavage. Pharmacologic inhibition of MMP-2 and MMP-9 produced similar
results. In another study, overexpression of dominant-negative Rac1 in human umbilical
vein endothelial cells prevented trans-endocytosis of ephrinB2/EphB4 complexes and
cell retraction111. However, it was unclear if abrogation of cell retraction was due to the
lack of endocytosis or the reduced Rac1 activity. If endocytosis or proteolytic cleavage is
required to render cell-cell separation, it would be interesting to know if the persistence
of complexes leads to signaling that promotes cell-cell adhesions, or if signaling during
endocytosis somehow imparts repulsive cues.
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Like most other RTKs, tyrosine phosphorylation of Eph receptor ICDs is
negatively regulated by a variety of tyrosine phosphatases.

Major phosphatases that

have been identified include low molecular weight protein tyrosine phosphatase (LMWPTP), protein tyrosine phosphatase, receptor type O (PTP-RO), and protein tyrosine
phosphatase 1B (PTP1B)47,114. PTP-RO is thought to selectively de-phosphorylate
juxtamembrane tyrosine residues in both EphAs and EphBs115, suggesting a role in
negative feedback of tyrosine kinase activity. Phosphatase activity may additionally play
a role in directing adhesive or repulsive outcomes. A study of EphA3 signaling in pre-B
leukemia cells suggested that increased endogenous activity of PTP1B changed the
response from repulsion to adhesion116.

Experimental techniques to cluster and activate Eph receptors
The requirement for receptor clustering in Eph receptor signaling has led many
groups to develop unique methods of inducing receptor clustering in vitro. Use of
antibody-clustered soluble ephrin ligands has been the most widely-used technique. To
accomplish clustering, the ECDs of ephrins are ligated to the crystallizable fragment (Fc)
of human IgG. These chimeras are dimerized by Fc cross-linking. Pre-clustering of
these dimeric ephrin-Fc chimeras by anti-Fc antibodies is done prior to treatment of cell
cultures11. An early study demonstrated an array of ephrin cluster sizes with antibodymediated clustering, with tetramers being the most effective to induce signaling42.
Multiple studies have demonstrated that freely-diffusing ephrins are also
sufficient to activate Eph receptors. Co-culture studies of ephrin-expressing and Ephexpressing cells, or of cell lines that contain an appropriate Eph/ephrin combination, have
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shown contact-dependent activation of Eph receptors60. In addition, studies have also
shown that lipid substrates functionalized with ephrin ECDs are also sufficient to activate
Eph receptor signaling in cells plated on top of them85.

This may reflect the

aforementioned observations that ephrins are capable of self-dimerization54, and perhaps
they may cluster on their own.
Both of the techniques described above have been used to provide a plethora of
information about Eph receptor signaling. However, spatial and temporal regulation of
signaling molecules are important to direct cell migration. The nature of Eph/ephrin
activation at cell-cell contacts necessitates sub-cellular regions of activation. Thus, prior
attempts have been made to achieve spatial and temporal control over Eph receptor
clustering. A study of contact inhibition of locomotion in prostate cancer cells simulated
the nature of cell-cell contacts by functionalizing microbeads, which were coated with
anti-Fc antibodies, with dimeric ephrin-Fc chimeras61. Since these microbeads are much
smaller than cells, these provided good models of sub-cellular cell-cell contacts and
imparted some spatial regulation of signaling. Chemical induction of Eph receptor
clustering was recently developed by inserting a variable number (one to three) of FK506
binding protein (FKBP) domains between the transmembrane and juxtamembrane
regions of EphB2 and treating with the cross-linking drugs AP20187 or AP188743.
Depending on the number of FKBP domains inserted into the Eph receptor sequence,
cross-linking produced clusters of different sizes. This tunability of cluster size allowed
the group to demonstrate that larger Eph receptor clusters generate stronger signals, and
to provide further evidence that aggregates larger than dimers are necessary for efficient
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signaling43. This technique allowed some degree of temporal control over signaling,
though drug treatments often exceeded 20 minutes, and there was no spatial control.
Each of these techniques offered their own advantages in controlling Eph receptor
signaling variables, though there is a role for additional techniques to combine multiple
effects to achieve simultaneous spatial and temporal control. Optogenetic techniques,
specifically those that induce protein-protein interactions, have been used to gain spatial
and temporal control over related receptor systems and cell signaling pathways. Many
applications have used the A. thaliana photoreceptor Cryptochrome 2, which will be
described in the next section.

Cryptochrome 2 in Optogenetics
Optogenetics describes the use of genetically-encoded, light-sensitive proteins to
control cellular signaling in vitro or in vivo using light, which is desirable to impart
spatial and temporal control over signaling117. Perhaps most famously, use of lightsensitive ion channels known as channelrhodopsins or halorhodopsins have been useful
for in vivo applications in neuroscience, such as mapping and analysis of neural
circuits118.

This discussion will focus on Cryptochrome 2, a blue light-sensitive

photoreceptor from Arabidopsis thaliana that has been used to control protein-protein
interactions with light.

Cryptochrome 2 and CIB1 in optogenetics
Cryptochrome 2 (Cry2) is a photoreceptor derived from Arabidopsis thaliana that
undergoes a yet-uncharacterized blue light-induced conformational change that allows it
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to bind the transcription factor CIB1119. This property is imparted by its N-terminal
photolyase homology region (PHR), which contains a flavin adenine dinucleotide (FAD)
chromophore that is responsible for blue light absorption. The protein also contains a Cterminal nuclear localization sequence (NLS), which is mutated or truncated for
optogenetic applications120.
Blue light-induced Cry2-CIB1 binding has been used in mammalian cells to
control protein translocation (Fig. 1.4, Movie 1.1) and protein-protein interactions using
light. Optogenetic applications of the Cry2-CIB1 system were first demonstrated by
Kennedy et al.120, who modified CIB1 by truncation (CIBN) to remove DNA-binding
domains. It was found that both truncated Cry2, leaving just the PHR, and full-length
Cry2 (with a mutated NLS) bound CIBN upon blue light illumination. Recruitment of
Cry2 to the plasma membrane was demonstrated by tagging CIBN with a C-terminal
CAAX (Ras) domain (Fig. 1.4). Analysis revealed seconds-timescale Cry2 recruitment,
with maximal plasma membrane signal ~15 seconds following a single photoactivation
pulse.

The off-rate, however, was slow, as cytoplasmic recovery required ~12.5

minutes120. The functionality of these blue light-induced Cry2-CIBN interactions was
demonstrated by blue light-induced gene expression using a split Gal4 promoter. The
DNA-binding domain of the promoter was ligated to Cry2, and the activation domain was
ligated to CIBN. A similar technique was used to achieve optogenetic control of Cre
recombinase by splitting the enzyme120.
Since this initial study, many groups have used the blue light-induced Cry2-CIBN
binding to recruit proteins to the plasma membrane120 (Fig. 1.4, Movie 1.1) or control
protein-protein interactions. In general, CIBN is tagged to the plasma membrane as
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shown in Fig. 1.4, and Cry2 is fused to a protein of interest in the cytoplasm. Much
attention has been paid to optogenetic manipulation of membrane lipids. For example,
Idevall-Hagren et al.121 used a fusion of Cry2 and phosphoinositide-5-phosphatase to
recruit the phosphatase to the plasma membrane and dephosphorylate PIP2 to
phosphatidylinositol-4-phosphate, PI(4)P.

PIP3 synthesis was also demonstrated by

inducing plasma membrane recruitment of the inter-SH2 domain of the PI3K regulatory
subunit (illustrated in Fig. 1.4). The iSH2 domain, in this case, is bound to endogenous
PI3K catalytic subunits, which are activated upon plasma membrane recruitment. This
technology was applied to show the effect of PI3K signaling on actin in axons and
growth cones122.

Photoactivatable Akt, a downstream effector of PI3 kinase, was

developed by ligating Akt to Cry2 and activating it by plasma membrane translocation123.
Use of the Cry2-CIBN system has not been limited to membrane lipids. Recently,
molecular motors were recruited to intracellular vesicles to control anterograde or
retrograde transport and their intracellular distribution124.

By using the previously-

described120 split galactosidase promoter, in vivo optogenetic control of gene
transcription was achieved in zebrafish125. Optogenetic inhibition and sequestration of
proteins have also been explored. Recruitment of RGS proteins to the plasma membrane
achieved optogenetic inactivation of G protein-coupled receptors126.

Lee et al.127

reported ligating CIB1 to a multimeric protein, in this case CaMKII, for blue lightcontrolled sequestration of a target protein ligated to Cry2. This technique was dubbed
light-activated reversible inhibition by assembled trap (LARIAT) and was successfully
applied to tubulin, Vav2, Tiam1, Rac1, RhoG, and Cdc42127,128.
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Use of the Cry2-CIBN optogenetic module resulted in an innovative optogenetic
toolkit for a wide variety of applications. The rapid timescale of Cry2-CIBN interactions
and the ability to spatially define patterns of stimulation proved highly desirable to study
cell signaling. However, these modules required overexpression of two artificial fusions,
which may have affected baseline cell behavior or caused technical problems with
transfection, especially in the case of large proteins. The next section will discuss the
unique properties of Cryptochrome 2 that have permitted its use as a single-component
module for optogenetic control of protein-protein interactions.

Cryptochrome 2 clustering in optogenetics
Recently, Cry2 was demonstrated to undergo blue light-induced clustering as a
cytoplasmic Cry2-mCherry fusion129 (Fig. 1.4, Movie 1.2). This clustering response was
rapid- in response to repeated pulses of blue light, Cry2 clusters appeared within 10
seconds and reached their half-maximal density in ~30 seconds. The recovery rate,
however, was much slower, as clusters dissipated with a ~5.5-minute time constant
(exponential decay).

The significance of this clustering for optogenetics was

demonstrated by controlling activation of β-catenin through clustering of an upstream
protein, LRP6c, and activation of Rac1 and RhoA through clustering. These techniques
represented single-component optogenetic activation of intracellular proteins, a primary
advantage of using Cry2 alone instead of the Cry2-CIBN module.

However, high

concentrations of wild-type Cry2, or Cry2PHR, were necessary to observe efficient
clustering130.

A later study reported that an E490G mutation in Cry2 (Cry2olig)

enhanced blue light-induced clustering, though the half-time of cluster recovery was
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extended from ~5.5 minutes to ~23 minutes in the cytoplasm130.
In light of these discoveries, numerous applications that exploit this clustering
property have been explored. An assay dubbed light-induced co-clustering (LINC) was
developed in conjunction with Cry2olig to query protein interactions by ligating the
“bait” to Cry2olig-mCherry and the “prey” to another fluorescent protein130. In response
to blue light, the Cry2-fused bait clusters and, if the bait and prey interact, binds the prey
by avidity, causing co-localizing clusters. Fluorescence recovery after photobleaching
was demonstrated in conjunction with LINC (LINC-FRAP) to study the kinetics of
binding. In another study, activation of C-RAF was demonstrated by Cry2-mediated
clustering, but was also shown to occur via Cry2-CIB1 interactions131.
Most recently, Cry2 clustering has been used to optogenetically control signaling
from transmembrane proteins. Receptor tyrosine kinases, for instance, are endogenously
activated by ligand-induced dimerization and, in some cases, clustering. Blue lightinduced activation of Trk receptors and FGFRs was achieved by ligating a Cry2-FP
fusion to the C-terminus of these RTKs132,133.

Another strategy, called clustering

indirectly using Cryptochrome 2 (CLICR), uses a two-component system to induce
clustering and activation of transmembrane proteins (illustrated in Fig. 1.4). Cry2 resides
in the cytoplasm, fused to a protein or protein domain that interacts weakly with the
receptor of interest. Blue light-induced clustering, by avidity, then causes binding of
these components and clustering of the transmembrane receptor. This was demonstrated
using β-catenin signaling and receptor tyrosine kinases, the latter by a cytoplasmic Cry2SH2 domain fusion134.
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Chapter II of this thesis reports the development of a Cry2-based optogenetic tool
for Eph receptor signaling. This tool was used to study Eph receptors in the context of
synaptogenesis at dendritic spines. The following section provides an overview of the
biology and development of dendritic spine synapses, and current knowledge of Eph
receptor, particularly EphB, signaling in this field.

Dendritic Spines and Filopodia
Dendritic spines are the mushroom-shaped protrusions of neuronal dendrites that
comprise the post-synaptic compartments of most excitatory, glutamatergic synapses in
the central nervous system (CNS)1. Structurally, dendritic spines contain a bulbous head
that is attached to the dendritic shaft by a thin neck, and this structure is maintained by a
dense actin cytoskeleton. This morphology allows spines to compartmentalize postsynaptic proteins and locally restrict post-synaptic signaling and electrical activity2,135.
Post-synaptic molecules, including glutamate receptors, cell adhesion molecules, and
important post-synaptic scaffolds, are concentrated at the post-synaptic density (PSD),
which is directly opposed to the pre-synaptic axon135.
Over time, dendritic spines undergo a phenomenon termed synaptic plasticity,
defined as changes in synaptic strength. Synaptic strength is modified by changes in
spine head size and the density of glutamate receptors, which affects electrical
conduction. Long-term potentiation (LTP) describes synaptic strengthening by spine
head enlargement and increased glutamate receptor content at the PSD.

Long-term

depression (LTD) is the weakening or loss of a spiny synapses135,136. LTP and LTD are
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thought to play important roles in memory formation and loss, respectively, in vivo.
Indeed, studies performed in vivo have shown changes in spine turnover and morphology
following sensory stimulation and motor learning137–139.
Dendritic spine density and shape are tightly regulated throughout development
and adulthood in humans to ensure normal learning and cognition. Abnormalities in
spine density and morphology are frequently associated with neurological disorders3.
For instance, Alzheimer’s Disease, a neurodegenerative disorder in older adults
characterized by progressive dementia, is associated with abnormal loss of dendritic
spines as an individual ages.

Fragile X syndrome, a genetic disorder that causes

intellectual disability, is associated with an abnormally high density of spines that do not
have well-formed spine heads3. Thus, studying the mechanisms of spine formation,
maintenance, and plasticity is crucial to understanding the underlying pathogenesis of,
and developing treatments for, many neurological diseases.

Dendritic filopodia
Dendritic spines are thought to derive from dendritic filopodia, the long, thin,
actin-based protrusions present on the dendrites of developing neurons135. They are
dynamic structures that have been observed to extend, retract, and bend on a timescale of
minutes4,140.

The idea of dendritic filopodia as spine precursor structures was first

suggested by observations of filopodia in cultured hippocampal neurons by Ziv and
Smith in 19964. Some filopodia, though typically dynamic, were observed to stabilize
upon contact with axons. Additionally, filopodia density was highest during the first
week in vitro and decreased during the second week, while dendritic spine density
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increased concurrently4. Electron microscopy studies of brain slices by Fiala et al. two
years later reported synaptic structures juxtaposed to contacts between dendritic filopodia
and axons5.

Thus, conventional wisdom holds that dendritic filopodia are dynamic

structures that explore the area surrounding dendrites in search of axons. A subset of
filopodia becomes stabilized upon making contact, and these filopodia ultimately
transform into dendritic spines4,5.
Further studies of the actin structures and dendritic filopodia and spines provide
more evidence supporting this model.

At the cytoskeletal level, dendritic filopodia

resemble dendritic spines more than “conventional” filopodia associated with growth
cones or lamellipodia135,141. Electron microscopy studies by Korobova and Svitkina
(2010)141 showed that, unlike conventional filopodia, dendritic filopodia display some
actin branching and do not contain the actin-bundling protein fascin. Not surprisingly,
given the presence of actin branching, the Arp2/3 complex is present in dendritic
filopodia, as are myosin and capping protein. This structure stood in stark contrast to the
long, parallel bundles of actin typically observed in conventional filopodia, but compared
well to the actin structure of dendritic spines141. Spine heads contained highly-branched
actin networks, with higher levels of the Arp2/3 complex and capping protein relative to
the spine neck. Perhaps the machinery necessary to form the highly-branched dendritic
spine head, including Arp2/3142 and capping protein143, is present on dendritic filopodia
to “prime” them for spine formation.
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Dendritic spine morphogenesis from dendritic filopodia
Mature dendritic spines are marked by a well-formed spine head and the presence
of post-synaptic scaffolding proteins, such as PSD-95, and the NMDA- and AMPAsubtypes of glutamate receptors (NMDAR, AMPAR) in the PSD. Studies showing the
similarity in actin structure between dendritic filopodia and spines underscore the
importance of actin reorganization to dendritic spine formation and synaptic plasticity.
Spine head formation and enlargement are directed by increased actin polymerization in
spines. In particular, nucleation of highly-branched dendritic actin through activation of
the Arp2/3 complex is important in the formation and expansion of spine heads135,142.
Additionally, actin directs the organization of post-synaptic proteins at the PSD and
membrane recycling of AMPARs, whose density in the PSD is correlated with synaptic
strengh135,144.
Certain patterns of neural activity are known to trigger synaptic plasticity. For the
sake of simplicity, spiny synapses that receive frequent glutamatergic input undergo
maturation, or LTP, to become stronger and longer-lasting136. Glutamatergic activity is
also thought to account for initial formation of the spine head145. Glutamate binding to
NMDARs, which are ionotropic receptors, is thought to direct spine formation and LTP,
in part, through an influx of extracellular calcium.

This causes activation of

calcium/calmodulin-dependent protein kinase II, a master regulator of signaling cascades
in dendritic spines that direct actin reorganization via the Rho GTPases Rac1, Cdc42, and
RhoA. This is accomplished through interacting with and phosphorylating GEFs6.
Most signaling pathways that alter actin polymerization in dendritic spine
morphogenesis and plasticity converge on the Rho GTPases Rac, Cdc42, and RhoA6,146,
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which also mediate filopodia formation and motility.

Overexpression of dominant-

negative Rac and Cdc42 mutants in cultured neurons reduced spine density and caused
immature dendritic protrusion morphologies15,147. Rac and Cdc42 are known to mediate
dendritic actin nucleation through the activation of Arp2/3 via the nucleation-promoting
factors WAVE1 and N-WASP, respectively135,146–148.

Their effector p21-associated

kinase (PAK) also positively influences dendritic spine formation6. RhoA-mediated
inhibition of the actin-severing protein ADF/cofilin was shown to be critical for LTP
induction135. RhoA is also known to signal myosin IIb through the activity of Rhoassociated protein kinase (ROCK). Inhibition of myosin IIb by blebbistatin caused
replacement of spines by dendritic filopodia, suggesting an important role in maintaining
spine morphology149.
It was observed that only a subset of dendritic filopodia that come into contact
with axons form stable contacts4. A study8 that imaged a fluorescent calcium indicator in
hippocampal slices revealed that stable contact formation between filopodia and axons
was associated with a high frequency of local dendritic calcium transients. Surprisingly,
both contact stabilization and calcium transients occurred in the presence of NMDAR
inhibitors8. Since contact seemed to be a triggering event for filopodia stabilization,
these results suggested a role for cell-cell recognition molecules in not only inducing
these calcium transients, but also for directing contact stabilization and dendritic spine
formation. A role for Eph receptors12, which were described in an earlier section, in
dendritic spine formation was identified years before these results were published. This
is discussed in the following section.
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EphB signaling in dendritic spine morphogenesis
A synaptic function of EphBs was first suggested when the NMDAR subunit NR1
was shown to immunoprecipitate with EphB2 from whole rat cortex and ephrinB1stimulated cultured cortical neurons20. A later study established a role for EphBs in
dendritic spine development by observing reduced dendritic spine density in hippocampal
neurons overexpressing kinase-inactive EphB2. This study also showed that EphB2mediated tyrosine phosphorylation of the proteoglycan syndecan-2 promoted spine
formation13.

A follow-up study demonstrated severely impaired dendritic spine

formation in dissociated primary hippocampal neurons and hippocampal slices from
EphB1/B2/B3 triple-knockout (EphB TKO) mice14. Interestingly, cultured neurons from
single EphB (EphB1, B2, or B3) knockout mice showed no defects in spine formation or
morphology, and double knockouts (different combinations of EphB1-B3) showed
defects less severe than in triple knockouts. Imaging of hippocampal slices revealed that
triple EphB knockout was necessary to reduce dendritic spine density in vivo. These
results suggested that the various EphB isoforms show some redundancy in
synaptogenesis. Additionally, treatment of cultured neurons with pre-clustered ephrinB
ligands increased dendritic spine density and spine head width, indicative of spine
formation and maturation, respectively15.
Studies of the signaling pathways responsible for EphB-induced dendritic spine
morphogenesis have converged on regulation of the Rho GTPases Rac1, Cdc42, and
RhoA. A summary is provided in Fig. 1.6. EphB2 has been shown to interact with the
Rac1 GEFs Tiam1 and kalirin-7 to affect dendritic spine morphogenesis and maturation,
respectively15,150. Treatment of cultured hippocampal or cortical neurons with ephrinB
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ligands caused recruitment of these GEFs to EphB2 clusters15,147,150. These interactions
depended on an intact EphB2 intracellular domain, but did not require the PDZ binding
motif, despite the fact that Tiam1 contains a PDZ domain151 and kalirin-7 has a PBM that
binds other synaptic PDZ domain adaptors152. It was recently shown that Tiam1 exists in
a complex with the Rac1-specific GAP Bcr, and EphB2 disrupts this complex to increase
Rac1 activation153. Interestingly, Tiam1 and kalirin-7 are both tyrosine phosphorylated
following EphB stimulation, though kalirin-7 showed no change in activity with this
modification15,150. It is thus questionable whether or not EphB2 stimulation of dendrites
and interactions with GEFs and GAPs directly leads to Rac1 activation. Use of the
Raichu-Rac1 FRET sensor showed dendritic Rac1 activation with ephrinB ligand
treatment153. In another study, however, lysates of hippocampal neurons treated with
ephrinB ligands showed no increase in active Rac1147. Thus, the functional consequences
of the interactions between EphB2 and Tiam1 or kalirin-7 are incompletely understood.
Biochemical analysis of hippocampal lysates demonstrated Cdc42 activity with
ephrinB treatment147. EphB2 was shown to recruit the Cdc42-specific GEF intersectin
into a complex with Cdc42 and N-WASP147, which then promotes F-actin nucleation.
Intersectin-l was shown to bind syndecan-2147, suggesting a mechanistic link between the
aforementioned interaction between EphB2 and syndecan-2 and dendritic spine
morphogenesis. The adaptor protein Numb was also shown to bind intersectin-1 and
complex with EphB2 and NMDARs147,148, indicating that EphB2 may coordinate changes
in actin polymerization with key electrophysiological elements of spine formation.
Signaling from EphB2 to RhoA in dendritic spine morphogenesis remains
controversial. EphB2 signaling was shown to cause degradation of the RhoA-specific
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GEF ephexin5 by UBE3A, thus promoting dendritic spine morphogenesis154.
Surprisingly, another study showed RhoA activation by ephrinB treatment of cultured
hippocampal neurons17. Further study demonstrated that EphB2 activates RhoA via a
complex containing Grb2, Src, focal adhesion kinase, and paxillin, to support dendritic
spine morphogenesis and maintenance17,155. The GEF responsible for activation in this
complex remained unknown. Presumably, degradation of ephexin5 by EphB2 did not
preclude RhoA activation by additional mechanisms. Perhaps the specific GEFs and
adaptors involved are important for maintaining the proper spatial or temporal regulation
of RhoA.
In addition to regulating Rho GTPases, EphB2 signaling also affects the synaptic
localization and function of the NMDA- and AMPA-type ionotropic glutamate receptors.
EphrinB1-Fc treatment of cultured cortical neurons induced co-localization of EphB2
clusters with the NR1, NR2A, and NR2B subunits of NMDARs, and EphB2 coprecipitated from cortical lysates with NR120. EphB2-NR1 binding was shown to be
mediated by the extracellular domains of the proteins20. EphB2 uniquely causes tyrosine
phosphorylation of the NR2B subunits, and increases current flow through and reduces
desensitization of NR2B-containing, but not NR2A-containing, NMDARs in a kinasedependent manner19. Synaptic and surface expression of NMDARs were also increased
by EphB2 stimulation19,20.

Given the established role of EphB2 in dendritic spine

morphogenesis, it seems that EphB2 signaling at axo-dendritic contacts may help the
initial localization of NMDARs to nascent synapses.

Additionally, tyrosine

phosphorylation of the NR2B subunit may potentiate the effects of glutamate, thereby
facilitating spine head formation and LTP. EphB2 has also been shown to co-localize
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with, and increase the synaptic targeting of, AMPARs. This interaction depends on the
PDZ-binding motif of EphB2, through binding of the PDZ domain protein GRIP1156.
This supports a role for EphB2 in synapse formation as well as maturation, since
AMPAR levels typically increase in synapses as they mature1.

EphB signaling in neuropathologies
Given the association between dendritic spine morphogenesis and normal
cognition and memory formation, it is not surprising that alterations in the EphB-Rho
GTPase signaling axes are associated with psychiatric disorders and neurodevelopmental
diseases.

Behavioral deficiencies and impaired hippocampal LTP were observed in

EphB2-KO mice, effects that were, interestingly, kinase-independent157. Development of
schizophrenia, a psychiatric illness characterized by psychosis and mood and cognitive
defects, was associated with copy-number mutations of EphB1158 and mutations of the
EphB effector kalirin-7159. UBE3A, which degrades tyrosine-phosphorylated ephexin5,
is involved in numerous disorders. Angelman syndrome is caused by a loss of UBE3A
function, and autism spectrum disorders are associated with duplication of the UBE3A
gene154. These links to EphB function are, however, indirect, though missense mutations
in EphB1 showed weak but insignificant correlations with schizophrenia159. This may be
explained by the redundant functions of the EphB isoforms in synaptogenesis14,159, such
that simultaneous aberrations in multiple isoforms may be necessary to perturb function
in a physiologically-significant manner.
A number of studies have linked EphB2 to the pathogenesis of Alzheimer’s
Disease, which is a neurodegenerative disease of old age characterized by severe
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progressive dementia. It is associated with abnormally reduced synapse density, the
accumulation of extracellular plaques consisting of oligomers of amyloid-β, derived from
the amyloid precursor protein, and neurofibrillary tangles composed of phosphorylated
tau protein160,161. In a mouse model of Alzheimer’s Disease, reduced EphB2 expression
is observed prior to disease manifestation162.

Overexpression of EphB2 rescued

behavioral defects and NMDAR-dependent LTP in Alzheimer’s Disease model mice and
prevents changes in cultured hippocampal neurons secondary to Aβ-oligomer
treatment163. Signaling to PI3K by EphBs reduced Tau phosphorylation, such that EphB2
was protective against AD progression101. It is unclear if aberrations in EphB2 signaling
are causal in, or the result of, AD progression, and further work is needed to clarify this
role.

EphB signaling and dendritic filopodia
An elegant study by Kayser et al. (2008)16 knocked down EphB2 in cultured
cortical neurons during different stages in development (days in vitro) and examined the
effect on dendritic spine density in mature neurons. This study showed that the ability of
EphB signaling to promote spinogenesis was restricted to DIV7-14, when filopodia are
most abundant4,16. Additionally, overexpression of EphB2 in EphB TKO neurons was
only effective to rescue dendritic spine density when performed at 3 DIV, rather than at
10 DIV. These results suggested a role for EphB signaling in dendritic spine formation
that was specific to the presence of dendritic filopodia. Therefore, observing how EphB
signaling alters filopodia motility, morphology, or density is therefore important to
understand how the filopodium-to-spine transition takes place.

44

A role for EphB signaling in dendritic filopodia formation is controversial. EphB
TKO neurons did not show an increase or decrease versus wild-type neurons of dendritic
filopodia density16, indicating no effect on formation. Findings of filopodia shortening
with ephrinB1-Fc treatment of cultured hippocampal neurons17 suggests, at least, that
EphB signaling does not promote filopodia formation. Elongation would be expected
from signaling that promotes filopodia formation. However, increased overall dendritic
protrusion density was separately reported in cultured hippocampal neurons following
ligand treatment15. Since protrusion density is a product of both formation and retraction,
EphB signaling may have induced further protrusion formation or stabilized extant
protrusions. Only the increases in dendritic spine and synapse densities were explicitly
quantified, such that an effect on filopodia formation could not be concluded.
The same study by Kayser et al. (2008)16 that demonstrated a temporallyregulated effect of EphB signaling on dendritic spine formation also quantified the effect
of EphB TKO on the motility of dendritic filopodia. This group found that filopodia in
EphB-TKO cortical neurons were less motile than those of wild-type neurons, and that
motility in the knockouts was rescued by overexpression of CA-PAK16. This study
indicated that EphB signaling may promote filopodia motility, thereby increasing their
axon-searching function. Rac1 and Cdc42, which are the major upstream regulators of
PAK, may play important roles in this regulation. However, since the cultures were
derived from EphB-TKO animals, all cells in the dissociated culture were devoid of
EphB1-B3. Given that EphBs are RTKs, their knockdown likely affected the expression
of other proteins. Therefore, the observed effects may have been indirect. Additionally,
a function for EphBs in stabilizing dendritic protrusions would be more consistent with a
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role in spine morphogenesis. Since EphBs are presumably activated at contacts, and
filopodia stabilize at these contacts, one might expect a negative effect on filopodia
motility.

On this note, knockout of EphBs may reflect an indirect effect of EphB

signaling, such as the impact on expression of other genes, but not necessarily what
happens upon ligand engagement at contacts.
How EphB signaling to the Rho GTPases affects the motility and morphology of
dendritic filopodia thus remains unclear. As mentioned in the opening section, this thesis
seeks to clarify this problem. It is possible that EphBs direct the stabilization of filopodia
upon contact with axons. They may serve to contribute to dendritic spine head formation.
Perhaps, even, the observed effects on the cytoskeleton are indirect. My approach to this
problem, and a summary of my findings, are described below.

Overview
As mentioned in the opening section, this thesis seeks to define the effect of EphB
signaling on the motility and morphology of dendritic filopodia.

To approach this

problem, we sought to gain spatial and temporal control over EphB signaling. Even
independently of their role in synaptogenesis, spatial and temporal regulation of signaling
events is important to the biology of Eph receptors. As cell guidance molecules, Eph
receptors must establish gradients of downstream signaling mediators in individual cells
to direct changes in cell migration164,165. To achieve this goal, we used the blue lightinduced clustering of the Arabidopsis photoreceptor Cryptochrome 2129,130 to design an
optogenetic tool, optoEphB2, to activate EphB2 signaling with spatial and temporal
specificity.

Our data showed rapid tyrosine phosphorylation, expected cellular
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phenotypes, and engagement of expected downstream effectors with optoEphB2
photoactivation, confirming activation of EphB2 signaling.
We used patterned blue light illumination to target activation of optoEphB2 to
dendritic filopodia and sub-cellular regions of dendrites to simulate the nature of axodendritic contact. Stimulation of filopodia resulted in branching and expansion of
filopodial tips in conjunction with F-actin accumulation.

Such results suggested

formation of branched actin networks in filopodia, which would be expected in
conjunction with spine head formation. Stimulation of the dendritic shaft showed
localized formation of filopodia-like structures that was dependent on the Arp2/3
complex, which nucleates actin branches, and accumulation of the plasma membrane
lipid phosphatidylinositol(3,4,5)-triphosphate (PIP3), which plays important roles in actin
polymerization. This suggests that EphB may direct formation of filopodia near sites of
axo-dendritic contact, thereby up-regulating the local density of potential contacts that
may develop into spines.
Functional outcomes of EphB signaling are highly cell type- and contextdependent. While our observations suggested a role for EphB2 in promoting dendritic
protrusions, Eph receptors as a whole are much better known for promoting repulsive
responses between cells. These responses would entail retraction of cell protrusions.
Interestingly, prior studies and our data showed that plasma membrane PIP3 content is
reduced downstream of EphB2 signaling when retractions occur. Our results therefore
also suggest that differential regulation of plasma membrane PIP3 content contributes to
the context-dependence of EphB2 signaling in different cell types.
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Figures
Figure 1.1
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Figure 1.1. PI3K activation and signaling downstream of receptor tyrosine kinases.
Receptor tyrosine kinases (RTK) frequently activate class I PI3 kinases through
recruitment of the regulatory subunit (p85 shown). This is typically accomplished by
engagement of the regulatory subunit SH2 domains by RTK phosphotyrosines or through
binding SH2 adaptors. Catalytic subunits (p110) are constitutively bound to regulatory
subunits and are activated by conformational changes in the regulatory subunit and
recruitment to their plasma membrane substrates. Ras GTPases are also known to
increase PI3K activity through direct binding of Ras-binding domains in the catalytic
subunits. The catalytic subunits phosphorylate phosphatidylinositol(4,5)-bisphosphate
(PI(4,5)P2, PIP2) on the plasma membrane to generate phosphatidylinositol(3,4,5)triphosphate (PI(3,4,5)P3, PIP3), which recruits downstream effectors via pleckstrin
homology (PH) or other lipid-binding domains. Important effectors include Akt and
GEFs and GAPs that activate or inhibit, respectively, the Rho GTPases. PIP3 can be
dephosphorylated to PIP2 by PTEN, and is also dephosphorylated by many lipid
phosphatases (not shown).
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Figure 1.2
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Figure 1.2. Structure and clustering of Eph receptors and ephrins. Eph receptors
and ephrins are both membrane-bound molecules and are activated at cell-cell contacts.
The two subtypes of ephrins, ephrinBs and ephrinAs, are structurally distinct. EphrinBs
are transmembrane proteins with unstructured intracellular domains that contain
conserved tyrosine residues (Y) and PDZ-binding motifs (PBM). These tyrosines
become phosphorylated upon activation by other RTKs and non-receptor tyrosine
kinases. EphrinAs are linked to the outer leaflet of the plasma membrane by
glycosylphosphatidylinositol (GPI). The Eph receptor extracellular domain consists of
the ligand-binding domain (LBD), a cysteine-rich domain (CRD) consisting of sushi and
epidermal growth factor (EGF)-like motifs, and two fibronectin-type III (FNIII) repeats.
The intracellular domain contains conserved tyrosine (Y) residues in the juxtamembrane
(JM) region that are important for kinase regulation, a kinase domain, a sterile-alpha
motif (SAM), and a PDZ-binding motif (PBM). Autophosphorylation (pY) of the
juxtamembrane tyrosines relieves intracellular autoinhibition, permitting substrate
phosphorylation by the kinase domain. While dimerization of Ephs is sufficient to induce
tyrosine phosphorylation, clustering is necessary for efficient signal transduction.
Residues in the LBD, CRD, and the N-terminal FNIII allow these domains to promote
clustering through cis receptor-receptor interactions.
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Figure 1.3
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Figure 1.3. Eph Receptor Pathways in Cell Adhesion, Migration, and Survival.
Depending on the cell context, Eph receptors can increase or decrease cell adhesion,
migration, proliferation, and survival through many of the same pathways activated by
other RTKs. These pathways most often converge on the Rho and Ras GTPases and
PI3K. EphAs activate the ephexin family of GEFs in multiple contexts to activate RhoA
and promote cell-cell repulsion. During growth cone collapse, 2-chimaerin is recruited
to EphAs by its SH2 domain to inhibit Rac1. However, Rac1 signaling is necessary for
endocytosis of receptor-ligand complexes during cell-cell repulsion, and Vav family
GEFs are thought to activate Rac1 in these situations. Rac1 may also be activated
through the GEFs DOCK1, associated with the SH2 adaptor Crk, and -Pix, which binds
the SH2 adaptor Nck. Nck may also signal PAK independently of Rac1 and Cdc42,
which was shown in growth cone collapse downstream of EphBs. When engaged by Eph
receptors, Crk also promotes adhesion and activates integrin signaling through the Ras
family GTPase Rap via the Rap-GEF C3G. Signaling through the NRTK Abl can reduce
cell adhesions by inhibiting Crk, dissociating it from C3G and p130Cas. Abl, however,
can also promote adhesions and increase cell proliferation through activation of cyclinD1.
Unlike other RTKs, Eph receptors are generally known to inhibit Ras and R-Ras,
typically by SH2 domain-mediated recruitment of p120RasGAP. R-Ras inhibition can
also occur by direct tyrosine phosphorylation. These activities reduce cell survival and
migration. Activation of Ras may occur through recruitment of the SH2 adaptors Shc
and Grb2, which bind the Ras-GEF SOS. Src family kinases serve a variety of functions
downstream of Eph receptors. This figure displays Src-mediated tyrosine
phosphorylation of ephexins and 2-chimaerin, which happens during EphA-mediated
growth cone collapse, though SFKs are activated by Eph receptors in many systems and
can phosphorylate a wide variety of downstream effectors. Reduction of phosphotyrosine
can occur through recruitment of protein tyrosine phosphatases, including LMW-PTP,
PTP1B, and PTP-RO. Multiple MMPs can cleave the ECDs of Ephs and ephrins, and
ADAM10 can cleave the ECDs of ephrins, to down-regulate signaling and facilitate cellcell repulsion.

53

Figure 1.4
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+ Blue Light

Figure 1.4. Cryptochrome 2 in Optogenetics. (a) Schematic showing blue lightinduced (blue arrows) binding between Cry2 and CIBN, a truncated mutant of the
transcription factor CIB1. In this example, CIBN is tethered to the plasma membrane and
blue light illumination recruits Cry2. (b) Confocal images of MCF7 cells co-transfected
with Cry2olig-mCherry and a CIBN-GFP fusion tagged to the plasma membrane with a
C-terminal CAAX sequence (K-Ras). Blue light (488-nm laser used to image GFP)
caused translocation of Cry2olig to the plasma membrane. Total acquisition time was
20.4 s. Scale bar, 10 m. (c) Schematic of blue-light induced (blue arrow) clustering of
a Cry2olig-mCherry fusion. (d) Confocal images of MCF7 cells transfected with
Cry2olig-mCherry, which clustered in response to blue light illumination (458-nm laser,
scanning simultaneously, 48.4 s acquisition). Scale bar, 10 m. (e) Optogenetic
activation of PI3K. A CIBN-GFP-CAAX construct is tethered to the plasma membrane
and co-expressed with a fusion between Cry2 and the inter-SH2 (iSH2) domain of the
PI3K regulatory subunit. The iSH2 domain binds endogenous PI3K catalytic subunits
(p110), which become activated upon blue light-induced plasma membrane recruitment.
(f) Schematic of clustering indirectly using Cryptochrome 2 (CLICR). Cry2 is tethered
to a specific downstream effector of a transmembrane receptor (shown as example), or
other protein of interest. Blue light-induced clustering of these effectors causes binding
to the receptor by avidity, thereby clustering and activating the receptor. Confocal
images (b and d) were taken on a Zeiss LSM510 confocal microscope, using a 488-nm
laser line to excite GFP and a 561-nm laser line to excite mCherry.
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Figure 1.5

a
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Figure 1.5. Dendritic filopodia make contact with axons and transform into
dendritic spines. (a) Dendritic filopodia are actin-based protrusions that arise from actin
patches on the dendritic shaft. (b) Dendritic filopodia extend, retract, bend, and
sometimes branch in search of pre-synaptic axons. Some filopodia form stable contacts
with axons. (c) Dendritic filopodia that form stable contacts with axons undergo
reorganization of the actin cytoskeleton to form dendritic spines.
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Figure 1.6
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Figure 1.6. EphB signaling in dendritic spine morphogenesis. EphBs signal GEFs
and GAPs that regulate the Rho GTPases Rac1, Cdc42, and RhoA to drive dendritic spine
morphogenesis. Interactions have been shown between EphBs and the Rac-GEFs kalirin7 and Tiam1, both of which are tyrosine phosphorylated by EphBs. The Rac-GAP Bcr
also interacts with Tiam1, and EphB2 disrupts this interaction. EphB2, the Cdc42-GEF
intersectin, and N-WASP form a signaling complex. Numb also binds EphB in complex
with intersectin. Both Rac1 and Cdc42 activate the Arp2/3 complex, through WAVE1
and N-WASP, respectively, and PAK, to promote dendritic spine formation and
maturation. Regulation of RhoA activity by EphBs in dendrites is more complicated.
EphBs are known to tyrosine phosphorylate the Rho-GEF ephexin5, leading to its
UBE3A-mediated ubiquitination and degradation. However, a signaling complex
involving Grb2, Src, and focal adhesion kinase (FAK) was shown to activate RhoA
downstream of EphBs via an unknown GEF. Downstream of RhoA, signaling through
ROCK and myosin is thought to affect spine morphogenesis, whereas LIMK/cofilin
signaling is thought to mediate spine stability. In addition, EphBs also interact with
syndecan-2 and glutamate receptors. The ECDs of the NMDAR and EphB2 were shown
to mediate binding, and EphBs were also tyrosine phosphorylate the NR2B subunit of
NMDARs to alter their conductivity. EphBs recruit AMPARs through the PDZ domain
scaffolding protein GRIP. Tyrosine phosphorylation of syndecan-2, a heparan sulfate
proteoglycan that promotes dendritic spine formation, has also been shown. EphrinB3
was shown to interact with EphBs in cis to inhibit spine morphogenesis.
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Movie Captions
Movie 1.1. Light-inducible plasma membrane recruitment of Cryptochrome 2.
Movie shows Cry2olig-mCherry signal in MCF7 cells co-expressing CIBN-GFP-CAAX.
Cells were imaged by confocal microscopy (Zeiss LSM510), co-scanning with a 488 nm
(GFP excitation, Cry2 photoactivation) and 561 nm (mCherry excitation) lasers. Rapid
translocation of Cry2 to the plasma membrane was observed with blue light illumination.
Movie 2.2. Light-inducible clustering of cytoplasmic Cryptochrome 2. Movie shows
Cry2olig-mCherry signal in MCF7 cells. Cells were imaged by confocal microscopy
(Zeiss LSM510), using a 561 nm laser to excite mCherry and simultaneously scanning
with a 458 nm laser to photoactivate Cry2olig. Cry2olig showed rapid clustering in
response to blue light.
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CHAPTER II: Development of an Optogenetic Method for Eph Receptor Activation

Attribution: This chapter contains excerpts and figures from the manuscript “Effects of
Localized EphB2 Activation on Dendritic Filopodia of Hippocampal Neurons” coauthored by Clifford Locke, Qingfen Yang, Kazuya Machida, Chandra Tucker, Yi Wu,
and Ji Yu. Qingfen Yang assisted with cloning procedures. Kazuya Machida ran the
phosphotyrosine blot (Fig. 2.2b) of whole cell lysates, performed the rosette assay,
constructed Figure 2.3a, c, and d, and edited the relevant portions of the Methods section.
Chandra Tucker provided the Cry2 mutant, Cry2olig, ahead of her manuscript on its
development. Drs. Betty Eipper and Richard Mains provided embryonic rat hippocampi.
The text was written by Clifford Locke and proof-read and edited by Ji Yu and Yi Wu.
Clifford Locke wrote the text, constructed the figures that were not otherwise attributed,
and performed all experimental work that was not otherwise attributed.
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Abstract
Eph receptors comprise the largest family of receptor tyrosine kinases in
mammals. Together with their membrane-bound ephrin ligands, they transduce cell-cell
contacts into changes in cell migration that affect cell positioning and tissue patterning
during developmental processes.

Spatial and temporal regulation of Eph receptor

signaling on the tissue and single cell levels is thus important to proper function, and
current in vitro stimulation techniques do not permit this level of control.

Here,

we develop an optogenetic tool (optoEphB2) that allows for light-controlled reversible
activation of EphB2 through blue light-induced clustering of the plant photoreceptor
Cryptochrome 2.

Biochemical analysis showed rapid blue light-induced tyrosine

phosphorylation and engagement of SH2 domain-containing effectors typical of EphB2
signaling.

OptoEphB2 also facilitated real-time monitoring of cellular responses to

EphB2 signaling that was targeted to specific sub-cellular regions. We thus developed a
method for spatial and temporal control over EphB2 signaling.

Introduction
Eph receptors comprise the largest receptor tyrosine kinase (RTK) family in
mammals, consisting of nine EphA and five EphB receptors10. They are named according
to their relative binding affinities for either glycosyl phosphatidylinositol (GPI)-linked
ephrin-A or transmembrane ephrin-B ligands, although it should be noted that receptorligand binding is promiscuous and ligand specificities are not absolute22,166. Because
both the receptors and their ligands are membrane-bound molecules, Eph receptors have
a unique property among RTKs that their signaling activation in vivo typically requires
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direct cell-cell contact. Additionally, Eph receptors rely on clustering for efficient signal
transduction41.

While Eph receptor dimerization is sufficient

for tyrosine

phosphorylation, efficient effector recruitment and resulting cellular phenotypes typically
require higher-order associations42,43. During development, Ephs and ephrins sense cellcell contacts and alter the actin cytoskeleton to guide cell migration and thereby control a
host of important biological processes, including axon guidance64, tissue patterning65,
angiogenesis167, and cell proliferation102. Dysfunction in Eph/ephrin signaling has been
linked to many pathological processes, such as various forms of cancer and Alzheimer’s
Disease24,168.
Proper cell guidance by Eph receptors and ephrins relies on precise spatial and
temporal control of their signaling, which is necessary during development to position
cells in the right place at the right time. On the tissue level, this is accomplished by
spatial gradients of Ephs and ephrins, and has been well-described for the role of Eph
receptors in axon guidance64. For example, Ephs are thought to act as repulsive cues to
guide retinal axons to their appropriate targets in the visual system, and this is important
for spatial mapping of visual fields in the central nervous system (CNS)64. In individual
migrating cells, cell-cell contact typically occurs at sub-cellular regions. Subsequent
directionality inherently requires establishing spatial gradients of activated receptors and
downstream signals across the cell165.
Multiple techniques have been developed to cluster and activate Eph receptors in
vitro. In most studies, dimeric Fc-ephrin chimeras are pre-clustered by anti-Fc antibodies
and then applied to cultured cells42. This technique is most commonly used, but does not
impart spatial or temporal control over signaling. A chemical oligomerization system
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was recently developed and used to tune cluster size and correlate it with signal strength.
This system was designed with 1-3 FKBP domains inserted into the EphB2 ICD, which
were cross-linked with the homodimerizers AP20187 or AP188743. This technique
appears to provide temporal control, though most drug incubations were 20 minutes or
longer, and spatial control was not demonstrated.

Additionally, antibody-coated

microbeads have been used to pre-cluster ephrins and study cell migration61.

This

technique simulates sub-cellular contacts, but does not permit temporal control and is
impractical for non-migratory cell types, such as neurons. Simultaneous spatial and
temporal control over signaling would be invaluable to precisely model cell-cell contacts
and study the dynamics of downstream signaling mediators.
Recent concurrent studies reported spatial and temporal control of Trk
receptors132 and FGFR133, other RTK family members, using the blue light-induced
clustering of Cryptochrome 2 (Cry2). Cry2 is a photoreceptor derived from Arabidopsis
thaliana that clusters in response to blue light absorption by the flavin adenine
dinucleotide (FAD) chromophore in its photolyase homology region (PHR)134. Here, we
report the development of optoEphB2, a genetically-encoded, photoactivatable EphB2.
Blue light-induced clustering of optoEphB2 caused rapid tyrosine phosphorylation and
recruitment of SH2 domain-containing effectors that typically bind endogenous EphB2
receptors.

Retraction of cellular protrusions in fibroblasts and axonal growth cone

collapse were also observed and agreed with studies that used ephrinB ligand stimulation.
Signaling was reversible and repeatable, and spatial restriction of clustering and cellular
phenotypes were demonstrated. We thus developed a versatile module for spatial and
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temporal control over EphB2 signaling that can be applied in a multitude of cellular
systems.

Methods
Antibodies, reagents, and plasmids
All chemicals used for the experiments were purchased from Sigma-Aldrich (St.
Louis, MO) unless otherwise specified. The mouse anti-phosphotyrosine antibody was
purchased from Cell Signaling Technologies (Danvers, MA). The mouse anti-tubulin
and rabbit anti-mCherry antibodies were purchased from Thermo Scientific (Waltham,
MA). IRDye 680- and IRDye 800-labeled secondary antibodies were purchased from LICOR (Lincoln, NE).
Cry2olig-mCherry (full-length Cry2 or its PHR with E490G mutation), lightinsensitive Cry2-mCherry (Cry2 with D387A mutation), and wild-type Cry2-mCherry
(full-length or PHR) were described previously120,129,130.

Human EphB1 (plasmid

#23930) and EphB6 (plasmid #23931) sequences were obtained from Addgene
(Cambridge, MA). The human EphB2 sequence was obtained from DNASU (plasmid
#80351). To create optoEphB2 plasmids, the Gateway cloning system (Invitrogen) was
used. A Gateway cassette (Invitrogen) was first introduced into the Cry2-mCherry or
Cry2olig-mCherry plasmids, N-terminal to the Cry2 sequences, to produce destination
vectors. An entry vector containing the myristoylation signal peptide was generated by
inserting the oligonucleotide sequence corresponding to the N-terminal signal peptide of
c-Src (MGSNKSKPK) into pDONR223 (Invitrogen). Entry clones containing the ICD
sequences of EphB1 (amino acids 564-984), EphB2 (amino acids 595-986), and EphB6
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(amino acids 328-729), with N-terminal myristoylation, were then created using a
standard PCR-based cloning procedure.

Finally, expression clones for optoEphB1,

optoEphB2, and optoEphB6 were made by LR recombination (LR Clonase, Invitrogen)
of the corresponding Cry2-based destination vectors and entry clones. The kinase-dead
optoEphB2 (KD-optoEphB2) construct was made by site-directed mutagenesis (K662M
in full-length EphB2, K98M in optoEphB2). To generate optoEphB2 clones containing
Venus, mCherry was excised and replaced with the yellow-fluorescent Venus sequence,
which was amplified by PCR.

A lentiviral vector carrying optoEphB2 (pLIX401-

optoEphB2) was made by excising the whole optoEphB2 sequence and subcloning it into
an inducible lentiviral expression vector, pLIX401 (Addgene plasmid #41390). The ArgYFP plasmid169 was a gift from Anthony Koleske.

Cell culture, transfection, and ephrinB1 Treatment
All cells were kept in a humidified 37C incubator with 5% CO2. HEK293,
HEK293FT, MCF7, MEF, and COS7 cells were maintained in Dulbecco’s Modified
Eagle Medium (Gibco, Grand Island, NY or Lonza, Basel, Switzerland) with 10% fetal
bovine serum (FBS, BioWest, Kansas City, MO) and penicillin/streptomycin (Gibco) at
100 U/ml penicillin and 100 g/ml streptomycin.

The medium used to maintain

HEK293FT cells was DMEM/FBS supplemented with 500 g/ml G418 (Gibco).
Transient transfections were carried out using Lipofectamine 2000 (Invitrogen, Grand
Island, NY) following the manufacturer’s protocol. To establish cells stably-expressing
optoEphB2 and KD-optoEphB2, pseudo-lentiviral particles were prepared.

Briefly,

pLIX401-based DNA was co-transfected into HEK293FT cells by calcium phosphate
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precipitation with the 3rd generation packaging plasmids pRRE, pMD2G, and pRSV
(Addgene plasmid #12251, #12259, #12253). Viruses were precipitated from cell culture
medium with PEG-it (400 g/L PEG 8000, 88 g/L NaCl) and concentrated by
centrifugation. The MEF Tet-off cells (Clontech, Mountain View, CA) were infected
with viral particles to produce the MEF-OptoEphB2 and MEF-KD-OptoEphB2 cells,
which were maintained in DMEM/FBS media supplemented with 300 µg/ml G418.
Primary hippocampal neurons were plated and maintained as previously
described170,171. Briefly, hippocampi were dissected from E17-19 Sprague-Dawley rats
and were mechanically dissociated. Some hippocampi were obtained from BrainBits,
and other tissue was a generous gift from Drs. Betty Eipper and Richard Mains. Cells
were plated onto plasma-cleaned 30-mm coverslips, that were coated with 0.05% poly-Llysine, at 90,000-100,000 cells/dish. Neurons were maintained in Neurobasal (Gibco)
with B27 (Gibco) at 1:50, GlutaMax (Gibco) at 1:400, and penicillin-streptomycin at 100
U/ml of penicillin and 100 g/ml streptomycin. FBS at 2% and 25 M glutamate were
also added at time of plating. Transfections were done using Lipofectamine 2000 and
BrainBits (Springfield, IL) Transfection Medium, following manufacturer’s protocol with
some modification. Transfections of neurons were carried out 24-48 hours prior to
experiments.

Biochemical assays
For western blot assays of phosphotyrosine, MEFs expressing optoEphB2 or KDoptoEphB2 were treated with blue LED light (~10-2 W/cm2), or incubated in the dark, for
1 minute. Cells were lysed in modified kinase lysis buffer (KLB, 150 mM NaCl, 25 mM
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Tris-HCl pH 7.4, 5 mM EDTA, 1 mM PMSF, 1% Triton-X-100, 10% glycerol, 0.1%
sodium pyrophosphate, 10 mM -glycerophosphate, 10 mM NaF, 5 g/ml aprotinin, 50
M pervanadate) as previously described172. 0.1% SDS was added to the KLB to aid in
solubilizing large optoEphB2 or KD-optoEphB2 clusters. Proteins from lysates were
separated by gel electrophoresis on 4-15% gradient polyacrylamide gels (BioRad,
Hercules, CA) in buffer containing 3.03 g/L Tris base, 14.4 g/L glycine, and 0.1% SDS.
For loading into wells, 2-mercaptoethanol was added at 1:200. Samples were transferred
to nitrocellulose membranes (General Electric Healthcare, Pittsburgh, PA) in buffer
containing 3.03 g/L Tris base and 14.4 g/L glycine. Membranes were blotted with mouse
anti-phosphotyrosine and rabbit anti-mCherry antibodies. Blots were visualized and
quantified on an Odyssey IR scanner (LI-COR) using secondary antibodies labeled with
IR dyes (rabbit IRDye 680 for mCherry, mouse IRDye 800 for pan-phosphotyrosine).
The membrane was stripped in buffer containing 2% SDS, 62 mM Tris-HCl pH 6.8, and
0.7% 2-mercaptoethanol at 55C, rinsed, and re-probed for anti-tubulin, which was
visualized with a mouse IRDye 800 secondary antibody.
Immunoprecipitation of optoEphB2 was carried out by first measuring the
concentration of protein in cell lysates by colorimetry with Bradford reagent using a
BioTek Synergy HT plate reader. Cell lysate containing 200 g of protein was mixed
with 2-4 g rabbit anti-mCherry antibody. Pulldown was done with 25 L of protein Acoated magnetic bead suspension (Invitrogen). Beads were pulled down using magnets,
washed with KLB (no SDS), denatured at 95ºC for 10 minutes, in the same buffer used
for gel electrophoresis plus 1:200 2-mercaptoethanol, and separated, transferred, and
analyzed by the aforementioned western blotting procedure. For photoactivation, MEFs
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in a 6-cm dish were illuminated with blue LED light bulb of 1W total optical power for 1
minute. Control cells were kept in the dark.
The dot-blot SH2 binding assay was performed as previously described172,173
using the lysates prepared for the phosphotyrosine assay. Briefly, aliquots of the MEF
lysates, or of lysates from pervanadate-treated cells (positive control) or phosphatasetreated cells (negative control), were spotted on a membrane. These aliquots were
incubated with purified glutathione-S-transferase (GST)-tagged SH2 domains and
detected by immunoblotting with horseradish peroxidase (HRP)-labeled anti-GST
antibodies, treating with an enhanced chemiluminescence (ECL) reagent (Perkin-Elmer),
and imaging on a Kodak Image Station 4000MM Pro with Carestream MI SE software.
The quantification shown in Fig. 2.3d represents the average intensity from triplicates,
normalized to the maximum signal derived from any of the optoEphB2 or KDoptoEphB2 treatment conditions.

Microscopy and Image Analysis
Most live cell imaging experiments were carried out on a Nikon (Tokyo, Japan)
Ti-E inverted fluorescence microscope with a 60x TIRF objective (NA = 1.49, Nikon).
Images were acquired with an iXon Ultra EM-CCD (Andor, Oxford Instruments,
Abingdon, Oxfordshire, UK).

The microscope was placed within a temperature-

regulated imaging chamber and cells were maintained at 37°C during imaging. For
imaging mammalian cell lines, cells were kept in DMEM/F12 (Gibco) containing 2%
FBS and 20 mM HEPES (Gibco). For imaging neurons, the cells were kept in imaging
medium containing 117 mM NaCl, 5 mM KCl, 1.25 mM NaH2PO4, 20 mM HEPES, 50
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mM dextrose, 1 mM MgCl2, 2 mM CaCl2, and 100 mg/L BSA, at pH 7.2. Neurons were
imaged in epifluorescence, using a 575-nm LED (Lumencor, Beaverton, OR) to excite
mCherry and mRFP and a 515-nm LED (Lumencor) to excite Venus. MEFs were
imaged in TIRF (total internal reflection fluorescence) mode. A 594-nm DPSS laser
(CrystaLaser, Reno, NV) was used to excite mCherry, and Venus/YFP was excited with a
515-nm DPSS laser (CrystaLaser).

TIRF and DIC imaging of optoEphB2 clustering in

293 and COS7 cells and ligand-mediated cell collapse in MEFs were carried out on an
Olympus (Tokyo, Japan) IX81 TIRF microscope equipped with a 60x TIRF objective
(NA = 1.49, Olympus) and a TE-cooled EM-CCD (PhotonMax, Princeton Instruments,
Trenton, NJ). The 488-nm line of an argon ion laser (Melles Griot, Carlsbad, CA) was
used to excite GFP and photoactivate optoEphB2, a 562-nm DPSS laser (CrystaLaser)
was used to excite mCherry, and a 442-nm DPSS laser (CrystaLaser) was alternatively
used for photo-activation of optoEphB2.
Spatial control of optoEphB2 on the Nikon Ti-E system was achieved using a
Mosaic illumination system (Andor) coupled to a 440-nm LED (CoolLED, Andover,
Hampshire, UK) on the Nikon Ti-E microscope, unless otherwise noted. The region of
illumination (ROI) was expanded to cover the whole mosaic for illumination over the
field of view.

Photoactivation of sub-cellular regions and growth cones were

accomplished by manually defining a ROI that encompassed the desired area.

For

growth cones, the entire growth cone area was covered, and the ROI was adjusted as
necessary for growth cone migration throughout the acquisition. Images for whole-cell
stimulation of MEFs were taken at 3 frames/min, with 50-ms pulses of photoactivation at
3.5% LED power delivered between frames. Growth cones were imaged at 6 frames/min
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with 100-ms pulses of photoactivation at 2% LED power. Alternatively, a 460-nm LED
(Prizmatix, Givat-Shmuel, Israel), or the 488-nm or 442-nm lasers on the Olympus IX81
system, were used for photoactivation where noted.
Maximum intensity projections of growth cones were generated using ImageJ
after background subtraction. Area was measured with manual thresholding, and the
same threshold was used for multiple projections from any one cell. The growth cones
were defined by the cellular area from the expansion point on the axonal shaft to every
point touched by protrusive structures. Two growth cones from the optoEphB2 group
were excluded due to problems defining the expansion point.

MEF cell area was

measured by measuring cellular area from the optoEphB2 signal after background
subtraction and sharpening using the Unsharp Mask function. Octane174 was used to
count optoEphB2 clusters.

Results
Design of optoEphB2
Eph receptors are typically activated in vitro by antibody-mediated clustering of
soluble ephrin ligands prior to treatment11,41,42. We hypothesized that light-induced
clustering would be sufficient for this, given the role of clustering in Eph receptor
signaling, and to ultimately achieve spatial and temporal control. Two concurrent
studies132,133 demonstrated activation of Trk receptors and FGFR, two other members of
the RTK family, by fusing Cry2 to the receptors’ C-terminus. We therefore ligated the
PHR of Cry2, which will be referred to simply as Cry2, and mCherry to the C-termini of
multiple Eph receptors (Table 2.1).

However, confocal microscopy of transfected

71

HEK293 cells revealed that Cry2 fusions involving EphB2 and EphB1 gave poor plasma
membrane localization, and large fluorescent puncta were detected in the cytoplasm (Fig.
2.1a).

We speculated that these puncta were internalization vesicles secondary to

receptor activation. This notion was supported by the fact that a construct consisting of
EphB6, a catalytically-inactive EphB subtype, showed relatively more plasma membrane
localization (Fig. 2.1a). It was possible that activation of Eph receptors was occurring
secondary to interactions with endogenous ephrins on other cells.

Alternatively,

Himanen et al.56 demonstrated increased tyrosine phosphorylation of overexpressed Eph
receptors. Mutation of extracellular domain (ECD) residues that are responsible for
interactions between receptors on the same cell surface mitigated the tyrosine
phosphorylation induced by overexpression56.
We therefore eliminated the ECD and, instead, tagged the intracellular domains of
the Eph receptors to the plasma membrane with an N-terminal myristoylation sequence
derived from c-Src (Table 2.1). A similar design was reported for optoFGFR133. This
modification improved plasma membrane localization (Fig. 2.1b).

However,

photoactivation and imaging by total internal fluorescence (TIRF) microscopy showed
that blue light-induced clustering was weak and inconsistent, insufficient for Eph receptor
activation (Fig. 2.1c). We then incorporated a recently-identified mutant, Cry2olig (Cry2
E490G), which has a higher tendency to form high-order clusters130. This was effective
to produce robust blue light-induced clustering (Fig. 2.1c). Two mutants of optoEphB2
(Table 2.1), kinase-dead optoEphB2 (KD-optoEphB2) and a light-insensitive optoEphB2
(LI-optoEphB2), were also constructed to serve as controls. The kinase-dead construct
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was made by introducing an arginine-to-methionine mutation in the ATP-binding pocket
of the kinase domain (K98M in optoEphB2, K662M in full-length EphB2).

Biochemical validation of optoEphB2
The final design of optoEphB2 is shown in Figure 2.2a. To test if opticallyinduced optoEphB2 clustering resulted in receptor activation, we assayed for tyrosine
phosphorylation in cell lysates of mouse embryonic fibroblasts (MEFs) stably expressing
optoEphB2 or KD-optoEphB2. We found that optoEphB2-expressing MEFs subjected to
blue LED light illumination for just one minute exhibited significantly higher overall
tyrosine phosphorylation compared to cells left in the dark (Fig. 2.2b). In contrast, blue
light produced no increase in tyrosine phosphorylation in cells expressing KDoptoEphB2 (Fig. 2.2a,b). The most significant increase in phosphorylation was observed
near 135 kDa, consistent with the size of optoEphB2. Anti-phosphotyrosine blot analysis
of immunoprecipitated optoEphB2 showed an approximately 29-fold increase of tyrosine
phosphorylation (Fig. 2.2b) in blue light-illuminated samples. These results verified
optoEphB2 kinase activation by blue light-induced clustering.
RTK phosphotyrosines typically serve as docking sites for Src homology 2 (SH2)
domains of various adaptor proteins30. For further biochemical validation of optoEphB2,
we screened for candidate SH2 domains that interacted with proteins in the whole cell
lysate.

To do this, we used a “rosette” assay as previously described172,173

Methods).

(see

Our results (Fig. 2.3) showed, in response to blue light illumination of

optoEphB2, significantly increased binding of SH2 domains that had been previously
shown to bind EphB2, including Abl104, Arg104, Crk175, RasGAP50,71, and Nck50. The
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SH2 domains of CrkL, Cten, and Fes were also shown to bind the lysate, but have not
been shown to interact with EphB2 in other studies. CrkL and EphA3, however, were
shown to interact176. It is likely that these SH2 domains are binding other tyrosinephosphorylated proteins in the lysate, or that these are the result of non-specific binding.
The SH2 domain of Src, whose binding of EphB2 is well-documented50,52,177, did not
bind the cell lysate in our experiment, but also failed to bind the positive control, and the
result is therefore inconclusive. To confirm these results, optoEphB2 or KD-optoEphB2
and Arg were co-expressed in 3T3 cells and formed co-localizing clusters upon blue light
illumination (Fig. 2.3b). These results show that SH2 domains that typically bind EphB2
are also binding phosphotyrosine motifs in our cell lysates, providing further validation
of optoEphB2.

OptoEphB2 confers spatial and temporal control over EphB2 signaling
We next asked if photoactivation of optoEphB2 produced the same cellular
phenotypes as those caused by ligand-mediated activation. Previous studies have shown
that a prominent cellular response to EphB activation is cell-cell repulsion, marked by
local retraction of cell protrusions or cell collapse10. Consistent with these previous
findings, we found that photoactivation of optoEphB2 in MEFs quickly induced cell
collapse (Fig 2.4a, Movie 2.1). OptoEphB2 clusters formed rapidly, with a time constant
of 14.9 seconds (Fig. 2.4b), in response to repeated pulses of blue light. Collapse of
protrusions commenced with a delay of ~2 minutes following the first photoactivation
pulse (Fig. 2.4b).

Quantification of cell area showed a greater than 60% overall

reduction, on average, with optoEphB2 activation, with 4/6 cells tested losing greater
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than 40% of cell area (Fig. 2.4b). In contrast, KD-optoEphB2 caused significantly less
cell collapse, and none of the cells lost more than 40% of their area (Fig. 2.4b). Cell
collapse was thus kinase-dependent as previously described10, and the KD-optoEphB2
results also suggested that collapse was not an effect of phototoxicity. Consistent with
this finding, stimulation of MEFs expressing EphB2-EGFP with pre-clustered ephrinB1Fc ligands, but not the Fc control, caused retraction of cellular protrusions (Fig. 2.4c).
The effects of optoEphB2 on cell morphology were also examined in HEK293 cells, in
which EphB2 was previously shown to cause cell collapse175, and MCF7 cells, whose
substrate attachment was reduced by ephrinB2 treatment178. OptoEphB2 photoactivation
also resulted in total collapse of HEK293 cells and reduced membrane ruffling and
lamellipodial protrusions in MCF7 cells, and these effects were not observed with KDoptoEphB2 (Fig. 2.4d,e).

To further rule out any effects of Cry2 or phototoxicity,

photoactivation of a myristoylated Cry2-mCherry fusion (myr-Cry2-mCherry) also did
not cause HEK293 cell collapse. These results confirmed functional EphB2 signaling
with blue light-induced optoEphB2 clustering.
Spatial and temporal control over signaling drives the development of optogenetic
modules.

When blue light illumination was restricted to sub-cellular regions of

optoEphB2-expressing MEFs and MCF-7 cells using digital light patterning179, we found
that both receptor clustering and cell retraction were spatially restricted to the region of
illumination (ROI), while non-illuminated regions were unaffected (Fig. 2.5a,b, Movie
2.2). These results demonstrated the ability of spatially controlling EphB signaling with
OptoEphB2. To test if optoEphB2 signaling can be reversed, we optically activated
MEFs and monitored the morphology changes after the removal of blue light illumination
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(Fig. 2.5c, Movie 2.3). We found that within ~5 min, the receptor clusters dissipated and
the cell started to re-expand by generating highly dynamic membrane protrusions (Fig.
2.5c, Movie 2.3). Furthermore, we found that the activation-deactivation cycles can be
repeated multiple times (Fig. 2.5c). Therefore, optoEphB2 allows for reversible and
repeatable activation of EphB2 signaling. This may be important to study the role of
EphB2 signaling in cell segregation, for instance, to determine signaling functions once
segregation is complete. The reversibility of the clustering of Cry2olig itself had been
previously examined130.

Interestingly, we found that the clusters of optoEphB2

dissipated much faster than previously reported for cytoplasmic Cry2olig-mCherry130.
The difference may reflect a change in spatial dimensionality from the cytosol (3D) to the
plasma membrane (2D), or may be related to EphB2 domain interactions or downstream
signaling events.

OptoEphB2 causes growth cone collapse in hippocampal neurons
To test whether OptoEphB2 is functional in neurons, we examined if OptoEphB2
activation induces repulsive responses in axonal growth cones43,45,62,91,92. Growth cones
of DIV5 primary hippocampal neurons co-expressing OptoEphB2 or KD-optoEphB2
(fused to Venus in lieu of mCherry) with mCherry (volume marker) were illuminated
with blue light. We acquired time-lapse images of the growth cones before and during
photoactivation. Growth cone collapse and retraction were frequently observed with
optoEphB2 photoactivation, but not with KD-optoEphB2 (Fig. 2.6a, Movie 2.4). To
quantify these effects, we measured the total area explored by the growth cone before and
after photoactivation (Fig. 2.6b). Because growth cone morphology is highly dynamic,
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the area was measured from maximum intensity projections of the image stacks,
compiled from the 5-minute period prior to, and the final 5 minutes of, blue light
illumination. These projections plot the maximum intensity recorded at each pixel during
the indicated 5-minute time frame and thereby account for each point that was touched by
the growth cone. We found that photoactivation reduced the maximum projection area in
10/12 growth cones expressing optoEphB2 (Fig. 2.6c). In 9/10 of growth cones with
reduced dynamics, a loss of greater than 20% was observed. With KD-optoEphB2, this
magnitude of reduction was only observed in 3/8 cases, and 4/8 growth cones showed
increased dynamic activity. Normalizing the final 5 minutes of photoactivation to the 5
minutes before, optoEphB2 reduced the area explored by growth cones to ~68% of the
original value, on average, while KD-optoEphB2 caused a marginal (~3%) increase in
dynamics (Fig. 2.6c).

These results confirm the role of optoEphB2 in reducing

hippocampal growth cone dynamics, in agreement with published results for EphB243.
To further understand this phenomenon, we classified growth cones into three
categories: lamellipodial, filopodial or blunt (Fig. 2.6d), following criteria used by an
earlier study180. Growth cones classified as “lamellipodial” contained predominantly
broad membrane extensions. “Filopodial” growth cones contained only long filopodia or
filopodia with small lamellipodial veils. “Blunt” growth cones contained no filopodia or
lamellipodia. For highly dynamic growth cones, a classification was assigned to each
frame of the time-lapse movie during the initial and final 5-minute segments, and the
most frequent classification was chosen. Only growth cones that were lamellipodial or
filopodial to start were considered for analysis. As shown in Fig. 2.6d, optoEphB2
activation promoted a filopodial or blunt morphology, observed in 5/14 and 3/14 growth
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cones, respectively, post-stimulation, compared to 2/14 filopodial growth cones prior. Of
the 12 growth cones that initially displayed lamellipodial morphology, optoEphB2 caused
4 to switch to filopodial and 2 to blunt. Only 1 of 7 lamellipodial growth cones became
filopodial with KD-optoEphB2 stimulation, and none became blunt.

This suggests

selective disassembly of dendritic actin networks in growth cones.

Discussion
Receptor tyrosine kinases, such as the Eph receptors, are often spatially and
temporally regulated to achieve desired signaling outputs165.

This is particularly

important in cell migration, where asymmetric signaling over the cell is necessary to steer
cells in the appropriate direction165. Concurrent studies by the Heo group achieved
spatial and temporal control over the Trk and FGF family of RTKs using
optogenetics132,133. Here, this technique is applied to Eph receptors, whose function in
cell migration and requirement of clustering for signaling render Cry2-based clustering
an ideal method for spatial and temporal control. Interestingly, our design required
Cry2olig, as opposed to wild-type Cry2 as reported for previous applications, for efficient
clustering on the cell surface. This held despite the fact that membrane-tagged wild-type
Cry2 demonstrated efficient blue light-induced clustering (Fig. 2.4d). It is possible,
however, that wild-type Cry2 produced clusters small enough as to not be visible. Or, the
design of the construct itself may have prevented Cry2 interactions between molecules,
perhaps by weak steric hindrance or limited degrees of freedom.
We used biochemical assays and microscopic imaging to ensure optoEphB2
behaved similarly to endogenous EphB2 in live cells. The SH2 screening assay revealed
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that phosphotyrosine residues in photoactivated cell lysates were capable of binding the
SH2 domains of Abl, Arg, Crk, CrkL, Cten, Fes, Nck, and RasGAP. Since we are using
whole cell lysates, our assay does not confirm or refute direct binding of these domains to
optoEphB2, since any of these SH2 domains may be binding to phosphotyrosine residues
on proteins other than, or concurrently with, EphB2. Indeed, multiple proteins displayed
increased tyrosine phosphorylation in response to optoEphB2 photoactivation (Fig. 2.2b),
so a multitude of sites are available for binding. The literature shows evidence of direct
binding between EphB2 and the SH2 domains of Abl104, Arg104, Crk175, Nck50, and
RasGAP50,71, and we thus suspect that they also bind optoEphB2 directly.

We suspect

indirect interactions for the CrkL, Fes, and Cten SH2 domains. However, we cannot
make these conclusions outright.
In practice, other techniques used to conclude direct binding to EphB2 are also
problematic, if less so. Prior EphB2-SH2 interaction assays frequently used pull-downs,
which may show indirect binding and often involve overexpression of SH2 domains or
use of GST-SH2 fusions, thereby artificially increasing SH2 domain concentrations.
These assays are thus susceptible to non-specific interactions and false positives. Other
in vitro screening techniques, such as yeast-two-hybrid, may not reflect conditions in
living cells. As such, techniques using only the SH2 domains, including the rosette
assay, may yield false negatives as well as false positives27. So, although we cannot
conclude direct binding with the rosette assay, we still conclude that the interactions
observed are consistent with native EphB2 signaling.
Interactions between EphB2 and Grb217, Vav290, and Src177,181 have also been
reported in the literature, though their SH2 domains did not show statistically significant
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binding of optoEphB2 lysates. For Src, this is not concerning because its SH2 domain
also showed relatively weak binding to our positive controls (Fig. 2.3c,d).

The

interaction with Grb2 was shown by immunoprecipitation from cultured hippocampal
neurons, but involvement of the SH2 domain was not explored17. Multiple other studies
reported negative results for interactions between the Grb2 SH2 domain and EphB250,182.
An interaction between Vav2 and both EphA4 and EphB2 were demonstrated by
immunoprecipitation, and deleting the Vav2 SH2 domain blocked its interaction with
EphA4. This was not explicitly tested for EphB2, and its interaction with Vav2 was
substantially weaker than it was for EphA490, suggesting that this may not be an
important interaction. Thus, despite the aforementioned problems with the rosette assay,
there is substantial agreement between the SH2 domains that we detected and SH2
domain binding interactions reported in the literature. This leads us to believe that
appropriate signaling pathways are being activated by optoEphB2.
As observed in many prior studies with ligand-induced EphB2 clustering, blue
light-induced optoEphB2 clustering yielded a substantial (~30 fold) increase in tyrosine
phosphorylation.

Only 1 minute of blue light illumination was necessary for this

response, suggesting robust temporal control over EphB2 signaling. The chemical
dimerization system, based on cross-linking FKBP domains inserted into Eph receptor
sequences, appeared to require drug incubations of at least 20 minutes to fully activate
the receptors. Most studies use ephrinB1-Fc treatments in excess of tens of minutes to
study Eph receptor signaling. For example, ephrinB1-Fc stimulation of COS1 cells,
which express EphB2 endogenously, required longer than 15 minutes to observe an
appreciable increase in tyrosine phosphorylation71. However, ligand stimulation has been
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reported to act more quickly in some studies. COS1 cell process retraction was initiated
within 5 minutes of ephrinB1-Fc treatment72, for example.

Neuroblastoma cells

overexpressing EphB2 showed increased tyrosine phosphorylation 5 minutes following
ligand stimualtion50. So, it is clear that, at least in some contexts, optoEphB2 offers a
substantial advantage in temporal control.
The other major advantage of optoEphB2 is spatial control. This may only be
achieved with soluble ligands by using special equipment to establish chemical gradients.
Astin et al.61 studied contact inhibition of locomotion in prostate cancer cells by
conferring spatial control with ephrin-coated microbeads. While this technique was
useful, it may not be extended to slowly- or non-migrating cells, and does not allow
temporal control over stimulation. OptoEphB2 permits user-defined, on-demand regions
of illumination to stimulate Eph receptors, representing a more efficient and customizable
method.
We thus conclude that light-mediated activation of optoEphB2 provides all the
advantages of the aforementioned techniques, while limiting any drawbacks.

We

demonstrated spatial control of signaling to user-defined regions of illumination and
showed reversibility and repeatability of signaling, such that any rebound effects may be
studied, where relevant. Since Cry2 clustering is tunable using light power and pulse
duration and frequency183 this technique may, too, be used to tune cluster size and study
cell responses. Additionally, transfection of multiple optoEph constructs allows for coclustering multiple Ephs simultaneously. However, this optical technique is not without
its flaws. The off-rate of Cry2 clustering is slow, thus analysis of short-lived Eph
receptor stimulation (less than tens of minutes timescale) is not possible. Additionally,
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the PDZ-binding motif is blocked by the Cry2-FP fusion, though our data suggest that
expected cellular phenotypes and effector recruitment persist despite this modification.
Overall, optoEphB2, and the other optoEphs, represent a versatile module for spatial and
temporal control over Eph receptor signaling that may be applied in a variety of cell
types.
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Tables
Construct
Cry2-mCherry

Diagram
Cry2

FP

Cry2olig-mCherry

Cry2olig

FP

myr-Cry2olig-mCh

Myr

EphB1/EphB2/EphB6-Cry2-mCh

Cry2olig

EphR

FP

Cry2

FP

OptoEphB2*

Myr

EphB2 ICD

Cry2olig

FP

KD-optoEphB2*

Myr

KàM

Cry2olig

FP

LI-optoEphB2*

Myr

EphB2 ICD

DàA

FP

Table 2.1. Nomenclature of constructs used to design and test an optogenetic tool for
EphB2 clustering and signaling activation. KD, kinase-dead. LI, light-insensitive. Cry2
or Cry2olig indicate the corresponding PHR, unless otherwise noted. FP, fluorescent
protein. Myr, myristoylation sequence derived from c-Src. EphR, Eph receptor. ICD,
intracellular domain. K→M, arginine-to-methionine mutation in the ATP-binding pocket
at position 662 of EphB2, or position 98 of optoEphB2. D→A indicates aspartate-toalanine mutation in Cry2 at position 387, rendering it insensitive to blue light by
disrupting FAD binding. This was done to full-length Cry2. *Versions containing fulllength Cry2olig were also made.
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Figures
Figure 2.1

84

Figure 2.1. Design iterations for optoEphB2. (a) Confocal microscopy images of
HEK293 cells expressing full-length EphB1, EphB2, or EphB6 fused to Cry2-mCh.
Most of the fluorescent signal appeared in punctate cytoplasmic structures with EphB2
and EphB1. EphB6 showed relatively improved plasma membrane localization. (b)
Confocal images of HEK293 cells expressing optoEphB2 with wild-type Cry2 or
Cry2olig. These constructs showed improved localization to the plasma membrane.
Confocal images in (a) and (b) were acquired on a Zeiss LSM510 confocal microscope,
using a 561-nm laser to excite mCherry. (c) TIRF microscopy images of optoEphB2
with wild-type (WT) Cry2 (COS7 cell) or Cry2olig (HEK293 cell) before and following
blue light illumination. COS7 cells were given 500-ms pulses of 488-nm laser light at 5second intervals for 85 seconds. HEK293 cells were given three 250-ms pulses of 488
nm light, 4.5 seconds apart. Scale bars, 10 µm.
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Figure 2.2
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Figure 2.2. Optogenetic activation of EphB2 tyrosine kinase activity. (a) Illustration
of optoEphB2 domain structure and the photoactivation process. Blue light illumination
induces Cry2 clustering, which results in receptor autophosphorylation (Y, tyrosine and
pY, phosphotyrosine) and downstream signaling. ICD, intracellular domain. FP,
fluorescent protein. Cry2olig indicates full-length Cry2olig or the PHR of Cry2olig. (b)
Left: western blot analysis of whole cell lysates collected from MEFs stably expressing
optoEphB2 or KD-optoEphB2 that were illuminated by blue LED light (~10-2 W/cm2), or
left in the dark, for 1 minute. Right: quantification of optoEphB2 phosphorylation.
Relative tyrosine phosphorylation was assayed in optoEphB2 immunoprecipitates and
quantified by dividing the phosphotyrosine signal by the mCherry signal. Error bars show
SEM (n=3).
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Figure 2.3
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Figure 2.3. OptoEphB2 signals SH2 domain proteins typical of EphB2. (a)
Illustration showing the position of each sample on any given rosette in the SH2
screening assay (see Methods) performed on the MEF cell lysates. Representative results
(Arg) are shown with relevant controls. (b) TIRF microscopy images of NIH3T3 cells coexpressing the indicated constructs prior to and following blue light illumination. Bottom
row shows overlay. Scale bar, 10 µm. (c) Rosettes for all SH2 domains tested. (d)
Quantification of rosette results. Values represent mean intensity of triplicates, measured
by densitometry, normalized to the maximum value of all experiments. Error bars, SD.
*p < 0.05 by two-way ANOVA. KD-L, KD-optoEphB2 treated with 1 minute of blue
light. KD-D, KD-optoEphB2 left untreated (dark). WT-L, optoEphB2 treated with 1
minute of blue light. WT-D, optoEphB2 left untreated (dark). Error bars, SD.
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Figure 2.4. OptoEphB2 activation causes reversible and repeatable cell collapse and
retraction of cell protrusions. (a) Time-lapse TIRF images of optoEphB2 or KDoptoEphB2 in MEFs during blue light illumination (50-ms pulses, 3 pulses/min.). Black
dotted lines trace initial cell area. (b) Top: Quantification of mean normalized MEF cell
area in response to blue light illumination of optoEphB2. Area at each time point is
normalized to the mean prior to photoactivation and averaged between cells. Error bars,
SEM. Bottom: OptoEphB2 cluster density (gray triangles) in response to continuous
pulses of blue light illumination. Each time point is normalized to the mean cluster
density prior to photoactivation and averaged between cells. This curve was fit (dotted
line) using an exponential to calculate the time constant () of 14.9 seconds. Error bars,
SEM. (c) DIC and TIRF microscopy images of MEFs transiently transfected with
EphB2-EGFP that were treated with pre-clustered ephrinB1-Fc chimeras (left) or human
Fc fragments (right) for 15 minutes. TIRF image shows EphB2-EGFP signal prior to
treatment. Dotted black lines trace initial cell area. (d) Left: TIRF images of optoEphB2,
KD-optoEphB2, or myr-Cry2olig-mCherry in HEK293 cells, before and 3 minutes
following blue light illumination (two 1-s pulses at 460 nm, gray triangles, 6
frames/min.). Right: Quantification of HEK293 cell area, normalized to the mean prior
to blue light illumination, and averaged between cells. Error bars, SEM. (e) TIRF and
DIC images of MCF7 cells expressing optoEphB2. TIRF images show optoEphB2 signal
before and following photoactivation (100-ms pulses, 440 nm, 6 frames/min.). The
kymographs correspond to the white dotted lines in the DIC images. Blue dotted lines
indicate the start of photoactivation. Scale bars, (a), (c)-(e), 10 m (unless otherwise
noted).
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Figure 2.5. Local optoEphB2 photoactivation causes spatially-confined clustering
and retraction of cell protrusions. (a) TIRF images of optoEphB2 in MCF7 cells
before and after focal blue light illumination (white circle, 10-ms pulses at 440 nm, 6
frames/min, 25 min.). (b) Time-lapse fluorescence images of optoEphB2 (MEF), which
was activated by blue light illumination (100-ms pulses, 6 pulses/min.) within the
specified region of illumination (ROI, black circle). Time labels are relative to the start
of photoactivation. (c) Time lapse TIRF images (top) of optoEphB2 (MEF) that was
photoactivated (100-ms pulses, 10-s intervals) over the indicated one-minute time
segments (blue, bottom), which were spaced at 10-minute intervals. Plot shows cell area
over time, normalized to the average cell area prior to the first stimulation (2 minutes).
Kymograph (bottom right) of the indicated region (dotted line) shows repeated formation
and dissipation of clusters, as well as cell shrinkage and expansion. Scale bars, 10 µm.
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Figure 2.6
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Figure 2.6. OptoEphB2 photoactivation causes growth cone collapse and retraction.
(a) Time lapse fluorescence images of mCherry (volume marker) in growth cones during
photoactivation (100-ms pulses, 3 pulses/min.) of co-expressed optoEphB2 or KDoptoEphB2. Examples of growth cone collapse and retraction in response to optoEphB2
stimulation are shown. Time labels are relative to the start of photoactivation. (b)
Maximum intensity projections of mCherry (volume) signal growth cones, constructed
from 5-minute time segments before, and at the end of, blue light illumination.
Illustration at top shows a timeline of the acquisition, indicating the relevant 5-minute
intervals (gray). (c) Plot shows normalized maximum projection area for each growth
cone. Maximum projection area for each growth cone was measured for the final 5
minutes of blue light illumination, and this value was normalized to the maximum
projection area calculated prior to blue light illumination. Diamonds indicate means,
error bars show standard deviations. *p < 0.05, t-test. (d) Analysis of growth cone
morphology before and after blue light illumination. Growth cones were classified as
lamellipodial, filopodial, or blunt (see text). Scale bars, (a), (b), (d), 10 μm.
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Movie Captions
Movie 2.1. OptoEphB2 photoactivation causes cell collapse in fibroblasts. Blue light
illumination (blue dot) of MEFs stably expressing optoEphB2 (Left) caused rapid cell
collapse, which was not observed with KD-optoEphB2 (Right).
Movie 2.2. Spatial regulation of optoEphB2 stimulation. Focal (blue circle at 2:00)
blue light illumination (blue dot) of optoEphB2 in MEFs results in spatially-restricted
clustering and cell protrusion collapse, without perturbation of the remaining cell area.
Movie 2.3. OptoEphB2 clustering and signaling are reversible and repeatable.
OptoEphB2 (MEF) is illuminated with blue light for 1 minute at 10-minute intervals.
After each illumination period (blue dot), there is rapid collapse of cell protrusions
followed by recovery of cell area. Repeated photostimulation causes additional collapse
and recovery cycles.
Movie 2.4. OptoEphB2 photoactivation causes growth cone collapse and retraction.
Movie shows mCherry (volume marker) signal in growth cones of DIV5 hippocampal
neurons. Photoactivation (blue dot) of optoEphB2 for 15 minutes resulted in growth cone
collapse (Left) and retraction (Center). Photoactivation of KD-optoEphB2 (Right) did not
affect growth cone dynamics.
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CHAPTER III: Local EphB2 Signaling Induces Branching of
Dendritic Filopodia, Expansion of Filopodia Tips, and Promotes
Dendritic Filopodia Formation

Attribution: This chapter contains excerpts from the manuscript “Effects of Localized
EphB2 Activation on Dendritic Filopodia of Hippocampal Neurons” co-authored by
Clifford Locke, Qingfen Yang, Kazuya Machida, Chandra Tucker, Yi Wu, and Ji Yu.
Qingfen Yang assisted with cloning procedures. Chandra Tucker supplied the Cry2
mutant, Cry2olig, ahead of her manuscript on its development. Ji Yu performed the
experiments and analysis that measured PIP3 levels in 3T3 cells and constructed Figure
3.4a-3.4d. Drs. Betty Eipper and Richard Mains supplied rat hippocampi. Anthony
Koleske provided Arg constructs and GNF2. Ji Yu and Yi Wu proof-read and edited the
text. Clifford Locke wrote the text, constructed all figures that were not otherwise
attributed, and did all experimental work that was not otherwise attributed.
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Abstract
Dendritic spines are believed to derive from dendritic filopodia by reorganization
of the actin cytoskeleton and recruitment of post-synaptic molecules. Previous studies
suggested that EphB signaling, initiated at contacts between axons and dendritic
filopodia, plays a critical role in this transition. However, the exact effects of EphB
signaling on the motility and morphology of dendritic filopodia have not been clearly
defined. We used optoEphB2, an optogenetic module for spatial and temporal control
over EphB2 signaling, to specifically stimulate EphB2 in dendritic filopodia and small
regions of dendritic shafts. Presumably, this would model local signaling at axo-dendritic
contacts.

Using this strategy, we found that localized EphB signaling at dendritic

filopodia promoted filopodia branching and plasma membrane expansion associated with
F-actin accumulation. Activation along the dendritic shaft also promoted actin nucleation,
but resulted in de novo formation of dynamic filopodia that was dependent on activation
of the Arp2/3 complex. Furthermore, we show evidence that local EphB signaling
resulted in an activation of phosphoinositide 3-kinase (PI3K), which marks a key
difference between signaling in dendrites and in fibroblasts, in which EphB signaling
causes retraction of cell protrusions. Combined, these results provided direct evidence of
actin polymerization in filopodia following EphB stimulation and suggested that
differential PI3K activity is important to adhesion versus repulsion downstream of EphB
signaling in neurons.

Introduction
In the central nervous system, EphBs are known to promote synaptogenesis and
dendritic spine development12. Inhibition of EphB signaling via genetic deletion or over99

expression of dominant-negative constructs resulted in reduced spine density and
dysmorphic spines in hippocampal neurons13,14. In vitro activation of EphB receptors
with pre-clustered ephrinB-Fc ligands rapidly increased the number of synaptic spines in
cultured rat hippocampal neurons at DIV1015. These results suggested that EphB
signaling at axo-dendritic contacts is a key event that drives the formation of dendritic
spines. Initial contacts likely form between axons and dendritic filopodia, which are thin
and transient actin-based protrusions on dendritic shafts that are most abundant in
immature neurons4,135. Dendritic filopodia are highly motile and thought to actively “seek
out” axons in order to establish contacts, which then may subsequently lead to EphB
activation and development of spines5,12. However, the exact effects of local EphB signal
activation on the morphology and dynamics of dendritic filopodia have never been
clearly defined, because in vitro activation of EphB receptors using soluble ligands
inevitably induces signaling globally in all cell types and cellular compartments. In
contrast, EphB signals in vivo, particularly at axo-dendritic contacts, are presumably
highly localized.
To examine dynamic responses of filopodia to local EphB signaling, we utilized
optoEphB2 to activate EphB2 signaling with precise spatial and temporal control. Signal
activation in dendritic filopodia of hippocampal neurons, in contradiction to previouslyreported results in fibroblasts and growth cones, promoted actin polymerization that
resulted in filopodia branching and membrane expansion.

Interestingly, focal

illumination of dendritic shafts resulted in de novo formation of filopodia-like
protrusions, associated with activation of PI3-kinase. Inhibition of Arp2/3 and Arg, an
upstream regulator of Arp2/3 signaling, also inhibited filopodia formation. While EphB2
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phosphatidylinositol(3,4,5)-triphosphate (PIP3) in dendrites, a reduction of plasma
membrane PIP3 was associated with cell process retraction in 3T3 cells. These results
suggested that differential regulation of PIP3 synthesis may account for the differences
seen between dendrites and other cell types. Our experimental results demonstrated the
mechanistic link between local EphB signaling and actin polymerization and provided
new insights into the role of EphB2 signaling in the dendritic filopodia-to-spine
transition.

Methods
Antibodies, reagents, and plasmids
Cloning of optoEphB2 and other optoEphB constructs, as shown in Figure 2.2a, is
described in the Methods section of Chapter II.

The light-insensitive optoEphB2

construct, containing the Cry2 D387A mutation as previously described129, was made by
subcloning fragments that contained the mutation into optoEphB2. OptoEphB2 and KDoptoEphB2 containing Cry2olig (full-length) were also made by subcloning DNA
fragments containing the C-terminal segment missing in the truncated versions130. These
clones containing Cry2olig were used for optoEphB2 photoactivation experiments in
neurons. OptoEphB2-PBM was made by subcloning a DNA fragment containing the
sequences for mCherry and the final 6 amino acids of EphB2 (IQSVEV) into optoEphB2,
taking the place of mCherry. The Lifeact-mCherry (plasmid #54491) construct was
obtained from Addgene. The PHAkt-mRFP plasmid was previously described121. The
myr-mCherry plasmid was prepared by recombination between an entry vector
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containing the myristoylation sequence and a destination vector containing mCherry
(Addgene plasmid #31907). The Arg-YFP and kinase-dead Arg-YFP (ArgKD-YFP)
sequences169,184 were gifts from Anthony Koleske. The kinase-dead Src-YFP (SrcKDYFP) plasmid was a gift from Yi Wu.

Cell culture, transfections, and drug treatments
Protocols for extraction, culture, and transfection of hippocampal neurons are
described in the Methods section of Chapter II. For treatment of neurons with LY294002
(Tocris) and DMSO, neurons transfected with optoEphB2 were initially photoactivated to
confirm protrusion formation and PHAkt accumulation. Cultures were then incubated in
the dark for at least 20 minutes to allow optoEphB2 clusters to dissipate, and were then
treated for 30 minutes with 50 µM LY294002 or a 1:200 dilution of DMSO, representing
the dilution factor from a 10 mM stock of LY294002. Photoactivation was then repeated
over the same region of illumination. Treatment with 5 µM cytochalasin D was initiated
immediately following the first photoactivation and continued for 30 minutes. For CK666 and GNF-2 (gift from Anthony Koleske) treatment in conjunction with dendritic
shaft stimulation, neuronal cultures were pre-treated with 200 µM CK-666 or a 1:50
dilution of DMSO for 30 minutes, or 10 μM GNF-2 or 1:1000 DMSO for 1 hour, prior to
photostimulation.

Microscopy and image analysis
Imaging conditions and photoactivation equipment are described in the Methods
section of Chapter II. To illuminate filopodia, ROIs were defined along the length of the
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dendrite, placed just far enough to avoid direct shaft stimulation, though spatial
confinement was not perfect. For focal illumination of dendritic shafts, the mosaic was
used to deliver blue light to a 40-pixel-diameter (~266 nm/pixel) circular region, unless
otherwise noted. Images for all dendritic shaft stimulation experiments were acquired at
3 frames/min, unless otherwise noted, and filopodia stimulation was acquired at 6
frames/min. Photoactivation was delivered in 50-ms pulses between frames, at 1% LED
power, unless otherwise noted.
Maximum intensity projections were generated after background subtraction and
drift correction using the “BG Subtraction from ROI” and the “StackReg” plugins,
respectively, in ImageJ. Images were sharpened using the “Unsharp Mask” function.
Maximum projection areas were measured within the ROI, using the same threshold
value for any given cell. Neurons were excluded if the dendritic shaft deformed within
the ROI during the acquisition. Only protrusions with greater than 0.5-μm length were
considered filopodia and analyzed for density or Lifeact content. Lifeact accumulation
was quantified by the mean Lifeact-mCherry intensity along a linescan that was manually
drawn along the center of a filopodium from base to tip. This was done for each
filopodium adjacent to, or falling within, the ROI at the first and last frames of
photoactivation. In the case of plasma membrane expansion, a region of interest was
drawn around the protrusion and the mean signal was quantified. For each cell, the mean
filopodium intensity for the final frame was normalized to that of the first frame, and
values were averaged between cells. Filopodia were examined for branching throughout
the photoactivation period, and only those filopodia within the ROI for greater than three
imaging frames were included. PHAkt-mRFP and mCherry accumulation were measured
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by normalizing the average intensity in the ROI, frame-by-frame, to the mean intensity
within the ROI throughout the 5-minute period prior to photoactivation.

Results
OptoEphB2 activation in dendritic filopodia induces actin polymerization that results in
branching and plasma membrane expansion
To understand effects of local EphB activation in dendritic filopodia, we
expressed either optoEphB2 or KD-optoEphB2 in DIV9-11 hippocampal neurons and
monitored cell morphology changes after signal activation. Cells were co-transfected
with either myr-mCherry, used as a membrane marker, or Lifeact-mCherry, to monitor
actin polymerization. Filopodia were stimulated by targeting blue light to a region of
illumination (ROI) oriented lengthwise along, but offset from, the dendritic shaft, and
imaging the optoEphB2 and KD-optoEphB2 signals showed confinement of clustering to
filopodia (Fig. 3.1a).

To our surprise, we found that stimulation of optoEphB2 in

filopodia resulted in a ~2-fold increased probability of filopodia branch formation (Fig.
3.1b, Movie 3.1), in comparison to the KD-optoEphB2 control. In some protrusions,
broadening of filopodia was observed, with formation of lamellipodia-like structures in a
small number of cases (Fig. 3.1e, Movie 3.2). The next section describes filopodia
formation following optoEphB2 clustering on the dendritic shaft.

No changes in

filopodia density were observed with stimulation at dendritic filopodia (Fig. 3.1c), further
confirming the desired spatial regulation. Dendritic filopodia are supported by a dynamic
actin cytoskeleton141. Therefore, we suspected that the observed changes in filopodia
morphology were caused by nucleation of actin filaments. To further characterize the
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effect of EphB2 on actin cytoskeleton, we quantified Lifeact-mCherry signals in filopodia
before and after blue light illumination. Significant accumulation of Lifeact signal (~57%
increase) was observed with OptoEphB2 stimulation in filopodia (Fig. 3.1d,f, Movie 3.1),
indicating increased F-actin concentration.

Local EphB2 signaling in dendritic shafts induces dynamic filopodia-like protrusions
EphB2 is expressed extensively along the dendritic shafts of hippocampal
neurons18. We therefore further examined whether EphB2 activation in the dendritic
shaft may also affect the actin cytoskeleton and cell morphology. Localized blue light
photoactivation (~10 µm diameter) was delivered to dendritic regions of DIV10-11
hippocampal neurons co-expressing mCherry, or Lifeact-mCherry, with either
optoEphB2, KD-optoEphB2, or light-insensitive optoEphB2 (LI-optoEphB2, contains
Cry2 with inactivating D387A mutation, see Table 2.1)129. We found that photoactivation
of optoEphB2 locally induced formation of dynamic dendritic protrusions that resembled
filopodia (Fig. 3.2a-c, Movie 3.3).

This phenotype was not observed with KD-

optoEphB2 (Fig. 3.2a,c) or LI-optoEphB2 (Fig. 3.2a), indicating that the effect requires
both clustering and kinase activity, and is not an effect of phototoxicity. In neurons cotransfected with Lifeact-mCherry, Lifeact accumulated in a punctate distribution on the
periphery of the dendrite in the ROI (Fig. 3.2b), indicating increased actin nucleation at
the base of newly-formed filopodia.
To quantify these morphological changes in dendrites, we generated maximum
intensity projection images over 5-minute segments of time-lapse images both before and
during the 15 minutes of photoactivation (Fig. 3.2b). The cellular area of a maximum
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intensity projection is affected by changes in the morphology and dynamics of the
dendritic filopodia, thereby measuring the area explored by the filopodial protrusions.
We found that the cellular area, including the area of dendritic shaft and the areas
explored by filopodial protrusions, increased significantly (~25%) after optoEphB2
activation, and became progressively larger during the 15-minute photoactivation period
(Fig. 3.2d). This occurred in a kinase-dependent manner, as KD-optoEphB2 did not
produce such an effect. After stimulation and letting the cells sit in the dark for 20 min,
we found that the number of dynamic filopodia was reduced to the pre-stimulation level.
A second round of blue light stimulation promoted new filopodial growth, indicating that
the stimulation is reversible and repeatable (Fig. 3.2e), as previously demonstrated in
MEFs (see Fig. 2.4). Finally, we also found (Fig. 3.2f) that the induction of filopodia can
be blocked by treatment with CK-666, an inhibitor of Arp2/3 complex, suggesting that,
similar to stimulation in filopodia, EphB2 activation in dendritic shaft also induces
branched actin nucleation, which in turn gives rise to formation of new filopodia185.
Additional tests were performed on other EphB family receptors. We found that
focal blue light illumination of hippocampal dendrites expressing optoEphB1 led to
filopodia formation in a similar manner to optoEphB2 (Fig. 3.3), while stimulation of
optoEphB6 did not produce filopodia formation (Fig. 3.3). EphB6 is different from all
other EphB members in that it is the only member that does not have a functional kinase
domain. Thus the results further verified that the kinase activity of EphBs is essential for
the effects on actin cytoskeleton. Additionally, these observations are consistent with
prior observations of functional redundancy among EphB isoforms in dendrites14. Since
the design of optoEphB2 blocks the C-terminus of the PBM, which is known to link
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EphB2 to downstream effectors and PDZ scaffolds that additionally bind glutamate
receptors, we wanted to confirm that our observations would hold with PBM-mediated
interactions. We thus subcloned the six C-terminal amino acids of EphB2 (IQSVEV),
containing the PBM (VEV), into the C-terminus of optoEphB2 (optoEphB2-PBM). We
suspected that PDZ binding would be restored, given the ability of isolated PBMs to bind
their respective PDZ domain partners186. Additionally, overexpression of an EphB2-YFP
fusion, in which YFP was inserted N-terminal to the PBM, was able to rescue spine
formation in EphB1-B3 triple-knockout neurons16. Local stimulation of optoEphB2-PBM
recapitulated the filopodia formation seen with optoEphB2 (Fig. 3.3), further validating
the physiologic relevance of our observations.

Differential regulation of PIP3 synthesis underlies cell context-dependent effects of
EphB2 signaling on the actin cytoskeleton
We observed that optoEphB2 photoactivation increased protrusive activity in
dendrites and caused collapse of protrusive structures in growth cones and MEFs. This
raises the question of how downstream EphB signals cause such differences in
phenotype.

Lin et al. recently studied EphB2-mediated CIL (contact inhibition of

locomotion) in motile cells and identified down-regulation of phosphatidylinositol(3,4,5)-triphosphate (PIP3) synthesis as a key downstream pathway98. Therefore, we set
out to investigate whether the effect on PIP3 synthesis is cell type-specific. First, we
sought to confirm that optoEphB activation also suppress PIP3 synthesis in fibroblasts
(Fig. 3.4a-d). Using a PIP3 sensor, the pleckstrin homology domain of Akt (PHAkt)
labeled with mRFP (PHAkt-mRFP)121,174, and total-internal-reflection fluorescence (TIRF)
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microscopy, we measured the spatial distribution of PIP3 in 3T3 cells (Fig 3.4a). As
expected, elevated PIP3 signal was found at the leading edges of cell protrusions, which is
evident from the intensity linescans (Fig. 3.4b) perpendicular to the edge of cell
protrusions. Upon optoEphB2 activation, we observed a rapid (< 1 min) decrease of
PHAkt intensity at the leading edge (Fig 3.4b). Importantly, the reduction of PHAkt
intensity preceded the retraction of cell protrusions. Retractions were initiated after 1
minute of stimulation (Fig. 3.4b). On average, we observed ~20% decrease in PHAkt
intensity during the first minute of photoactivation (Fig. 3.4c) near the leading edge (1
µm from the cell edge). A smaller decrease was also observed at the interior of the cells
(5 µm from cell edge), but the decrease was not statistically significant (Fig. 3.4d).
Overall, these results confirm the recent study98 and indicated that optoEphB2 elicits a
similar pathway to EphB2.
Different results were observed in hippocampal dendrites using the same PIP3
sensor. In DIV10-11 hippocampal neurons, we found coincidental PHAkt accumulation in
the ROI (Fig. 3.4e-g, Movies 3.3-3.5) when we activated optoEphB2 and observed
formation of filopodial protrusions. Epi-fluorescence microscopy was used here because
TIRF microscopy was not suitable for imaging dendrites, which are not adherent to glass
substrates. Therefore, the intensity of a volume marker, mCherry, was also measured to
control for a potential artifact due to volume changes. We found that the average signal
change is 29.8% for PHAkt, compared to 5.0% for mCherry, after 15 minutes of blue light
illumination (Fig. 3.4f), suggesting that volume change was not a significant factor and
PIP3 accumulation was primarily responsible for the PHAkt signal increase. Therefore,
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regulation of PIP3 synthesis downstream of EphB2 is cell type-dependent and may play a
role in regulating adhesive versus repulsive responses downstream of EphB2 activation.
To further validate the role of PIP3 synthesis in the observed signal outcome, we
used a PI3K inhibitor, LY294002, to block PIP3 synthesis. To minimize effects of cell-tocell variability, we performed the comparison experiments on the same dendrite in a pairwise fashion. Specifically, we first performed focal photoactivation of optoEphB2 as
described earlier to confirm the induction of actin polymerization and filopodia growth.
The cells were then incubated in the dark for at least 20 minutes to disperse optoEphB2
clusters, followed by treatment with either LY294002 or DMSO (control) and restimulation of the same ROI (Figure 3.5a,b). Quantification of PHAkt intensity in the ROI
showed that LY294002 treatment eliminated PHAkt accumulation, which was maintained
in DMSO-treated controls (Fig. 3.5a,b, Movies 3.3 and 3.4). In addition, LY294002
treatment resulted in abrogation of filopodia formation (Fig 3.5a,b). Finally, to see
whether the induced PIP3 synthesis was upstream of F-actin synthesis, as opposed to be a
consequence of it187, we inhibited actin polymerization using cytochalasin D during the
second round of stimulation (Fig. 3.5c, Movie 3.6). Yet, we still observed increased PIP3
signal comparable to the first round of stimulation (Fig. 3.5c). Therefore, we conclude
that PI3K activity was necessary for both the observed PIP3 synthesis, and formation of
optoEphB2-induced protrusions.

Filopodia formation by optoEphB2 depends on Abelson family kinases
Our previous experiments established a role for Arp2/3 activity in filopodia
formation downstream of optoEphB2 and binding of phosphotyrosines in cell lysates to
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the SH2 domain of Arg. Arg, also known as Abl2, is a non-receptor tyrosine kinase
(NRTK) that enriches in dendritic spines and functions in dendritic spine stability and
maintenance103. Arg is known to activate the Arp2/3 complex through the actin-binding
protein (ABP) cortactin, which plays an important role in dendritic spine formation188.
We thus hypothesized that Arg is mechanistically involved in regulating actin dynamics
downstream of optoEphB2 in neurons. To test this hypothesis, DIV11-12 neurons were
co-transfected with Arg-YFP and optoEphB2-mCherry and photostimulated as described
for filopodia formation. After photoactivation, optoEphB2 and Arg signals co-localized
in the ROI, suggesting an interaction (Fig. 3.6a). Co-expression of kinase-dead Arg, but
not kinase-dead Src, with optoEphB2 reduced the area explored by filopodia following
stimulation (Fig. 3.6b). Kinase-dead Src overexpression aids in controlling for nonspecific SH2 binding, since the Arg and Src SH2 domains are known to bind the
juxtamembrane tyrosines of EphB250,104,177. Additionally, treatment of neurons with the
allosteric Arg inhibitor GNF-2 reduced the area explored by filopodia (Fig. 3.6c). We
thus conclude that Arg is functionally linked to EphB2 in regulating actin dynamics in
dendrites.

Discussion
A key advantage to using an optogenetic method of receptor stimulation is tight
spatial and temporal control over signaling. We took advantage of this property to
directly interrogate the effects of local EphB2 signaling in dendritic filopodia, thereby
simulating the scenario of local contact formation with axons. Results from prior studies
that addressed this question were inconclusive. Cortical neurons from EphB1-B3 triple
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knockout mice did not show any defect in the density of dendritic filopodia16, conflicting
with reports of increased dendritic protrusion density following ephrinB1-Fc treatment of
cultured hippocampal neurons15.

Triple-knockout neurons also displayed impaired

filopodial motility16, but this does not address the question of the effect of ligandmediated stimulation on filopodia motility.
Our optogenetic technique expanded on prior work by allowing real-time
observation of protrusion morphology with simultaneous stimulation of EphBs targeted
to dendritic filopodia. We observed minutes-timescale increased actin polymerization in
filopodia, ultimately resulting in branching and plasma membrane expansion. Given that
filopodia and spines are supported by a dense actin network141, such expansion of the
membrane would suggest direct nucleation of dendritic actin networks by EphB signaling
in filopodia. In fact, this model is more consistent with studies that suggested Rac1
activation and a Cdc42-N-WASP-Arp2/3 signaling complex downstream of EphB2 in
dendrites15,147,148,150. Dendritic spine heads contain dendritic actin networks, and as such,
our findings may link EphB signaling to initiating spine head formation. Further detailed
studies of actin in filopodia and spine head markers would be necessary to draw these
conclusions.
Focal stimulation of EphB signaling along the dendritic shaft caused local
formation of numerous filopodia-like protrusions. Previous reports suggested that EphB
signaling increased dendritic spine and overall protrusion density15, but did not
specifically address the formation of dendritic filopodia.

Our findings would thus

suggest that EphB signaling may increase dendritic spine density by not only converting
filopodia to spines, but also by generating new filopodia near sites of axo-dendritic
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contact to serve as a “positive feedback” mechanism to form more spines. Given that
filopodia formation was confined to areas of optoEphB2 clustering, it is possible that
EphBs “hone” filopodia formation to sites of axo-dendritic contact.
Interestingly, the formation of filopodial protrusions was blocked by Arp2/3
inhibition, suggesting a role for dendritic actin nucleation. While dendritic filopodia are
unique in containing some actin branching, they still predominantly contain linear actin
networks, except for the triangular filopodia base141. Our data showed accumulation of
F-actin predominantly at the periphery of the dendritic shaft, suggesting that EphB
signaling may promote the formation of branched actin patches to serve as new sites for
filopodia formation. Additionally, neurons from EphB1-B3 triple-knockout mice, while
failing to form spines in culture, formed F-actin patches on dendritic shafts, suggesting a
shift in axo-dendritic contact sites from protrusions to the dendritic shafts14. Since
EphB2 is highly expressed along hippocampal dendritic shafts18, promoting actin
polymerization on the shaft likely has some functional role in dendrite or dendritic spine
morphogenesis. EphB signaling may ensure that, even at axo-dendritic contacts along the
dendritic shaft, proper spine formation ensues. This result may also suggest that the
branching and plasma membrane expansion induced in dendritic filopodia also occur
secondary to Arp2/3 complex activation. This provides more evidence for the nucleation
of dendritic actin networks in filopodia.
One recent study of EphB signaling in neurons showed reduced Tau
phosphorylation, and subsequent mitigation of Alzheimer’s Disease progression, by
EphB2-mediated PI3K signaling101. PI3K activation by EphBs was also implicated in
activation of peripheral and central pain pathways99,100. Thus, activation of PI3K by
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EphBs in neurons is known, and our results provide the first evidence that connects PI3K
signaling to the actin cytoskeleton in dendrites and dendritic protrusions downstream of
EphB2. Given the known roles of EphBs12 and PI3K189–191 , independently, in promoting
dendritic spine morphogenesis, these results are not surprising. PI3K is also known to
increase the motility of dendritic filopodia downstream of RTKs, such as Trk receptors,
that are activated by neurotrophins192.
Our observations of PI3K activation may be relevant in light of Rho GTPase
regulation by EphBs in neurons.

We recently demonstrated that sub-cellular PI3K

signaling had a strong impact on polarization of Rac1 activity in migrating cells174. EphB
signaling is also known to activate Rac1, and other Rho GTPases, in hippocampal
dendrites12.

Therefore, it is plausible that PI3K activation may contribute to Rac1

activation observed downstream of EphB signaling. Perhaps, local accumulation of PIP3
serves to spatially coordinate Rac1 activity at sites of axo-dendritic contact. This may
occur through the recruitment of GEFs. The pleckstrin homology domains of Tiam1193
and intersectin194, and the sec14 domain of kalirin-7195,196, have all been shown to interact
with PIP3.
Effects of Eph receptor signaling on the actin cytoskeleton are highly contextdependent. Initially, Eph receptors were thought to primarily mediate repulsive cues,
which are correlated with the inhibition of actin polymerization10,98. But later evidence,
particularly in cancer and dendritic spine morphogenesis, indicated that Eph receptors
mediate a much broader array of cell behaviors. This included promoting cell-cell or
cell-matrix adhesion and cell migration24.

The underlying mechanisms of this cell

context-dependence remain poorly understood. Our observations suggest that differential
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regulation of PI3K, or plasma membrane PIP3 content, contributes to this phenomenon.
Our observations and prior studies98 of EphB2 signaling suggest down-regulation of
plasma membrane PIP3 content in conjunction with retraction of cell protrusions. When
we observed a protrusive phenotype in hippocampal dendrites, local accumulation of PIP3
was observed.

Activation of PI3K was found necessary for this accumulation and

formation of filopodia-like structures.
Further studies are necessary to determine the underlying mechanisms of such
differential regulation. Differences in protein expression and effector binding between
cell types, or between axons and dendrites, are likely involved. This mechanism was
suggested in a study of differential Ras/MAPK regulation by EphB4. In human umbilical
vein endothelial cells, EphB4 inhibited the Ras/MAPK pathway through p120RasGAP.
In MCF7 breast cancer cells, EphB4 promoted Ras/MAPK signaling in a PP2Adependent manner, and p120RasGAP was not expressed79. Since multiple Ras isoforms
are involved in the regulation of PI3K36, it is possible that differential regulation of Ras
also underlies our observed context-dependent effects on PIP3 synthesis.

Down-

regulation of Ras by EphB signaling is well-documented in conjunction with
p120RasGAP72. Numerous potential pathways exist for EphBs to activate PI3K. In
dendrites, a signaling complex of EphB, Src, focal adhesion kinase, and Grb2 formed
following ephrinB ligand treatment17. In another context, EphB1 was shown to activate
Ras through the Ras-GEF SOS by recruiting the adaptor Grb2 through Shc76. Thus, SOS
may be responsible for Ras activation and downstream PI3K signaling. GAB1 is another
potential binding partner of Grb2 that is known to activate PI3K197. EphB2 was shown to
interact with the SH2 domain of a p85 regulatory subunit of PI3K in vitro, which would
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result in PI3K activation36,50.

Differences in kinase-dependent and –independent

signaling may also account for the discrepancies. An in vivo study of EphB signaling in
intestinal crypts showed kinase-independent activation of PI3K to promote cell
migration102, though a mechanism was not shown. Overexpression of kinase-dead EphB2
has been reported to impair spine development13,14, supporting a role for a kinasedependent mechanism and, perhaps, differential regulation of kinase-dependent
downstream effectors in different systems.
Our results demonstrated a role for the non-receptor tyrosine kinase Arg in EphBmediated protrusion formation. This interaction between EphB2 and Arg in neurons is
not unexpected, as EphB2 and Arg have been shown to interact in a positive-feedback
mechanism, and Arg is enriched in dendritic spines103,104. However, EphB2, especially in
the DIV10-11 age of neurons studied, has been primarily shown to drive the formation of
dendritic spines16. Arg, however, has been shown to promote dendrite and dendritic
spine stability and maturation, since dendritic spines develop normally in Arg-knockout
mice until adulthood198,199. While EphBs likely play a role in spine stability as well, no
studies have linked them to Arg in spine stability, let alone in spine formation. It should
be noted that the SH2 domains of Abl and Arg are similar and that GNF-2 allosterically
inhibits both. Our results may thus suggest a novel role for Arg, or Abl-family kinases in
general, in the regulation of dendritic spine morphogenesis by EphBs.
The findings in this chapter thus suggested a new model by which EphBs may
promote the formation of dendritic spines. Instead of simply supporting a transition from
filopodia to spines, EphBs may play a role in the formation of new dendritic filopodia
that can form additional contacts with axons. Our findings of differential PIP3 synthesis
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in protrusive versus repulsive responses should prompt future work on the underlying
mechanism. Our findings have, thus, further elucidated important biological questions
about the nature of EphB signaling in multiple cell types, and raised some interesting
questions for future studies.
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Figure 3.1. OptoEphB2 activation in dendritic filopodia causes filopodia branching
and plasma membrane expansion. DIV8-11 neurons co-expressed optoEphB2 or KDoptoEphB2 and either myr-mCherry or Lifeact-mCherry. Blue light (50-ms pulses, 6
pulses/min) was delivered to specifically stimulate filopodia. (a) Top: Illustration
showing orientation of blue light illumination to stimulate filopodia. Bottom:
Fluorescence images of optoEphB2 and KD-optoEphB2, showing clustering in filopodia.
Scale bar, 5 m. (b) Percentage of filopodia that showed increased branching or showed
plasma membrane expansion in response to photoactivation. n = 154 filopodia from 11
cells for optoEphB2, n = 191 filopodia from 7 cells for KD-optoEphB2. (c)
Quantification of protrusion density in response to photoactivation of optoEphB2 or KDoptoEphB2. For each neuron, protrusion density along the ROI was measured at the start
and end of blue light illumination. The end value was normalized to the start value, and
the numbers shown represent the average of all cells. Error bars, SEM. N.S., no
significance (t-test). (d) Quantification of Lifeact intensity in filopodia. Normalized
intensity was calculated cell-by-cell by averaging the intensity in all filopodia along the
ROIs before and after illumination, normalizing to the pre-illumination value, and
averaging between cells. Error bars, SEM. *p < 0.05, t-test. (e) Time lapse images of the
myr-mCherry signal in photostimulated filopodia. (f) Time lapse images of LifeactmCherry in filopodia during photoactivation. Time labels in (e) and (f) are relative to the
start of photoactivation.
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Figure 3.2. Local optoEphB2 clustering induces dynamic filopodia-like protrusions
on dendrites of hippocampal neurons in a manner that depends on Arp2/3 activity.
(a) Left: Time lapse images of mCherry (volume marker) in DIV10-11 neurons during
blue light illumination (50-ms pulses, 3 pulses/min.) of the indicated optoEphB2
construct over the ROI shown (white circles). Right: Fluorescence images of optoEphB2,
or mutant, before and after photoactivation. Time labels are relative to the start of
photoactivation. (b) Time lapse images of Lifeact-mCherry in a DIV11 neuron coexpressing optoEphB2 that was photoactivated over the ROI (white circle). (c)
Maximum intensity projection images of mCherry (volume marker), from the dendritic
segments shown in (a) that express optoEphB2 and KD-optoEphB2. Projection images
were constructed from 5-minute time segments before and during photoactivation. (d)
Quantification of increased filopodial protrusions. Dendritic areas within the ROI were
measured from maximum intensity projections (c) and normalized to measurements
before photoactivation. *p < 0.05, t-test, comparing optoEphB2 to KD-optoEphB2. (e)
Maximum intensity projection images of mCherry (volume marker) in DIV11 neurons
co-expressing optoEphB2. OptoEphB2 was photoactivated (Stimulation 1) over the
indicated ROI (white). After 20 minutes of incubation in the dark, photoactivation was
repeated (Stimulation 2). Protrusive activity was reduced to baseline then re-stimulated
to a level similar to the first photoactivation. (f) Neurons co-expressing mCherry and
optoEphB2 were pre-treated for 30 minutes with DMSO or 200 μM CK-666 (n=16 for
each). The image panels show maximum intensity projections of the mCherry signal
over the indicated timeframes. The Kolmogorov-Smirnov plot shows the cumulative
probability of the normalized maximum intensity projection areas within the ROI. This
was calculated by normalizing the value calculated from the final 5 minutes of
photostimulation to that of the 5 minutes preceding photostimulation. Scale bars, (a)-(c),
(e), (f), 5 μm.
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Figure 3.3. Optogenetic stimulation of optoEphB1, optoEphB6, and optoEphB2PBM. Time lapse fluorescence images of optoEphB1, optoEphB6, or optoEphB2-PBM
in DIV11 neurons. OptoEphB1 and optoEphB6 were imaged and stimulated over the
indicated ROI (blue circles) as previously described for optoEphB2 (see Methods).
OptoEphB2-PBM was imaged at 6 frames/min and photoactivated (440-nm light,
between frames) over an ROI (blue circle) ~8 m in diameter. OptoEphB1 and
optoEphB2-PBM stimulation resulted in formation of protrusions, while stimulation of
optoEphB6 did not. Time labels are relative to start of photoactivation. Scale bar, 5 m.
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Figure 3.4
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Figure 3.4. Differential regulation of PIP3 synthesis downstream of EphB2 in
dendrites and fibroblasts. (a) TIRF images of PHAkt-mRFP (PIP3 probe) in a 3T3 cell
co-expressing optoEphB2 and stimulated with blue light (442 nm laser). (b) Intensity
linescan of PHAkt signal near the cell leading edge as indicated by the dashed line in (a).
Each line (from the darkest to the lightest) indicates a different time point with 30 sec
spacing. (c) Quantification of PHAkt sensor intensity at the leading edge (1 m from cell
edge). Time points represent 1 minute before (Before), the start of (- Blue Light), and
after 1 min. of (+ Blue Light) blue light stimulation (n=6). *p < 0.05, t-test, comparing to
“Before.” (d) Quantification of PHAkt intensity at the cell interior (5 m from cell edge),
using the same time points as in (c) . (e) Time-lapse images of PHAkt-mRFP or mCh in
dendrites of DIV10-11 neurons during photoactivation (ROI, white circles) of optoEphB2
and filopodia formation. (f) Quantification of PHAkt or mCherry accumulation within the
ROI upon optoEphB2 activation and filopodia formation in neurons. Values represent
mean fluorescence intensity within the ROI normalized to the mean prior to
photoactivation and averaged between cells. Error bars, SEM. (g) Maximum intensity
projections of PHAkt-mRFP in dendrites before and after optoEphB2 photoactivation over
the ROI (white circles). Scale bars, (a), (e), (g), 5 µm.
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Figure 3.5
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Figure 3.5. OptoEphB2 activates PI3K in dendrites to induce PIP3 accumulation.
(a) Left: Fluorescence images of PHAkt-mRFP dendrites before and after two rounds
optoEphB2 stimulation (ROI, white). The top row shows the first stimulation. The
neurons were then incubated in the dark and treated with the PI3K inhibitor LY294002.
Re-stimulation is shown in the bottom row. Right: Quantification of PHAkt-mRFP
intensity in the ROI, normalized to the mean signal prior to blue light illumination. Error
bars, SEM (n=3). (b) Same as in (a) except, that neurons were treated with DMSO
(control) instead of LY294002. Error bars, SEM (n=3). (c) Maximum intensity projection
images of PHAkt-mRFP in a dendritic segment. OptoEphB2 was photoactivated (white
circle; ~8 μm, 50-ms pulses, 10-s intervals), incubated in the dark, and re-illuminated
following treatment with 5 µM Cytochalasin D, similar to (a) and (b). Plot on the right
shows PHAkt-mRFP signal normalized to the mean prior to illumination for both
stimulations. Scale bars, (a)-(c) 5 µm. All time labels are relative to the start of
photoactivation.
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Figure 3.6
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Figure 3.6. OptoEphB2 promotes dendritic filopodia formation by signaling through
the non-receptor tyrosine kinase Arg. (a) Time lapse images of DIV10-11
hippocampal neurons co-expressing ArgKD-YFP and OptoEphB2, before and after blue
light illumination (white circle; 50-ms pulses at 20-s intervals). (b) Maximum intensity
projections of optoEphB2 signal in DIV10-11 neurons co-expressing ArgKD-YFP,
SrcKD-YFP, or YFP, over the indicated time frames. Plot at right shows normalized
maximum projection area, calculated by dividing the area over the final 5 minutes of
photoactivation by that of the 5 minutes preceding photoactivation. Error bars, SEM.
*p<0.01, t-test. (c) DIV11-12 neurons co-expressing optoEphB2 and mCherry were
photostimulated after incubation with DMSO or 10 μM GNF-2 for 1 hour. GNF-2
treatment reduced the average normalized maximum intensity projection area, measured
during the final 5 minutes of photoactivation. Error bars, SEM. *p<0.01, t-test. (d)
Maximum intensity projections of mCherry signal in DIV11-12 neurons, co-expressing
optoEphB2, that were pre-treated with DMSO or GNF2 as in (c). Photoactivation was
delivered over the ROI shown (white). Scale bars, (a), (b), (d), 5 μm.
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Movie Captions
Movie 3.1. OptoEphB2 activation causes filopodia branching and F-actin
accumulation. Lifeact-mCherry signal in filopodia from DIV9 neurons co-transfected
with optoEphB2 (Left) or KD-optoEphB2 (Right). Branching and Lifeact accumulation
occur with focal blue light illumination (blue dot) of optoEphB2.
Movie 3.2. OptoEphB2 activation in filopodia forms lamellipodia-like protrusions.
Movie of myr-mCherry signal in DIV9 neurons, co-expressing optoEphB2, that shows
formation of lamellipodia-like protrusions from filopodia following localized optoEphB2
stimulation (starts at 0:00).
Movie 3.3. Local stimulation of optoEphB2 in dendrites induces formation of
filopodia-like protrusions. Movie of mCherry signal in DIV11 neurons co-expressing
optoEphB2 (Left) or KD-optoEphB2 (Right). Following focal (blue circle at 5:00) blue
light illumination (blue dot) of optoEphB2, numerous filopodia-like protrusions form.
Movie 3.4. Filopodial protrusions are associated with PI3K activation and PIP3
accumulation. Movie of PHAkt-mRFP signal in DIV11 neurons co-expressing
optoEphB2. Blue light illumination (blue dot) of optoEphB2 caused accumulation of
PHAkt (Left) in the ROI (blue circle at 5:00). After incubating in the dark and treating
with 50 M of the PI3K inhibitor LY294002, neurons were re-stimulated (Right) and
both PHAkt accumulation and protrusion formation were abrogated.
Movie 3.5. Formation of filopodial protrusions is reversible and repeatable. Movie of
PHAkt-mRFP signal in DIV11 neurons co-expressing optoEphB2. PHAkt-mRFP
accumulation in the ROI (blue circle at 5:00) was observed (Left) with dendritic
protrusion formation in response to focal optoEphB2 photoactivation (blue dot). Both
accumulation and protrusion formation were repeatable upon re-stimulation after 30
minutes of DMSO treatment (Right).
Movie 3.6. PIP3 accumulation occurs in the absence of actin polymerization. PHAktmRFP accumulation in the ROI (blue circle at 0:00, then at 5:00 following cytochalasin
D treatment) was observed with dendritic protrusion formation in response to focal
optoEphB2 photoactivation (blue dot). During re-stimulation, treatment with 5 µM
cytochalasin D blocked protrusion formation, but did not prevent repeated accumulation
of PHAkt-mRFP.
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CHAPTER IV: Discussion and Future Directions

Attribution: This chapter was proof-read by Ji Yu and Yi Wu. Clifford Locke wrote the
text.
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Summary
In neurons, EphB signaling was originally studied in the context of axon
guidance62. It was found that EphBs, among other Eph receptors, acted as repulsive cues,
and Eph/ephrin expression gradients targeted axons to their appropriate destinations64. A
role for EphBs in dendritic spine formation was first described when overexpression of
kinase-dead EphB2 caused impaired dendritic spine formation in cultured hippocampal
neurons13.

Genetic studies would later reveal that EphB1, EphB2, and EphB3 are

collectively essential for the normal formation of dendritic spines14.

Additionally,

stimulation of cultured neurons with pre-clustered ephrinB ligands induced dendritic
spine formation and spine head enlargement15.
Dendritic filopodia are thought to give rise to dendritic spines by forming stable
contacts with axons, and subsequent reorganization of the actin cytoskeleton4,200. To
better understand the role of EphBs in this process, previous studies addressed the effect
of EphB signaling on the motility and morphology of dendritic filopodia. Cultured
neurons from EphB1-B3 triple knockout (TKO) neurons showed reduced filopodia
motility versus wild-type neurons16, though this did not address the effect of ligand
binding. Filopodia density was unaffected in these neurons16, contrasting with another
study that reported increased total protrusion density following stimulation of cultured
hippocampal neurons with pre-clustered ephrinB ligands15. These results were, therefore,
inconclusive regarding the effects of EphB signaling on filopodia at sites of axo-dendritic
contact.
I became interested in the effect of EphB signaling on the morphology and
motility of dendritic filopodia to better understand how EphBs affect the actin
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cytoskeleton to induce spine morphogenesis. Given the role of clustering in EphB
signaling, and the recent report of blue light-induced clustering of Cry2129, I decided to
use an optogenetic approach to model local axo-dendritic contacts and target stimulation
to filopodia. Concurrent development of other blue light-controlled RTKs132,133 supported
this idea. Such a technique would allow real-time monitoring of filopodia motility,
morphology, and downstream signaling proteins following local EphB2 stimulation.
Chapter II reported the development of optoEphB2 for optogenetic control over
EphB2 signaling. Blue light illumination of optoEphB2 resulted in rapid tyrosine
phosphorylation and binding of SH2 domains to phosphotyrosine residues in cell lysates.
The corresponding SH2 domain proteins mirrored those known to act downstream of
EphB2. Expected cell-cell retraction phenotypes were demonstrated in MEF, HEK293,
and MCF7 cells and axonal growth cones. Spatio-temporal control over optoEphB2 was
confirmed by showing reversibility and repeatability of clustering and signaling, and
confinement of both clustering and expected phenotypes to sub-cellular regions of
illumination.
Chapter III focused on the effect of EphB signaling on actin in dendritic filopodia
and along the dendritic shafts. With targeted optoEphB2 clustering, filopodia displayed
increased actin polymerization and branching, some to the extent of showing plasma
membrane expansion, indicative of a highly-branched, or dendritic, actin network. On the
dendritic shaft, optoEphB2 clustering promoted the formation of filopodia-like structures,
which depended on the accumulation of phosphatidylinositol(3,4,5)-triphosphate (PIP3)
downstream of phosphoinositide-3 kinase (PI3K).

Given the reduction of plasma

membrane PIP3 associated with EphB2-mediated cell collapse, differential regulation of

132

plasma membrane PIP3 could represent a mechanism for the cell context-dependence of
Eph receptor signaling.
This thesis reports the successful development of a photoactivatable Eph receptor
that may be used in a variety of contexts.

Activation of optoEphB2 in dendritic

protrusions and along dendritic shafts improved our understanding of EphB signaling in
the development of dendritic spines.

A greater mechanistic understanding of the

differences between EphB signaling in dendrites and other cell types was also achieved.
My final comments on this thesis are given in this chapter.

Discussion and Future Directions

Development of an optogenetic method for Eph receptor activation
A primary goal of this thesis was to target EphB signaling to dendritic filopodia.
Optogenetic clustering using Cry2 was an intriguing method, and our design was
achieved after multiple iterations. After just one minute of blue light illumination, we
achieved robust tyrosine phosphorylation and binding of multiple SH2 domains.
Collapse of MEFs, localized cell process retraction, and growth cone collapse were
observed with patterned blue light illumination of transfected cells, in agreement with
previously observed phenotypes of EphB2 signaling. Our data suggest that we have a
functional optogenetic module for spatial and temporal control over Eph receptor
signaling.
Using an optogenetic tool for Eph receptor signaling will permit assays for the
spatial and temporal regulation of downstream signals. This is especially important for
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the Rho and Ras GTPases, which are important downstream effectors of Eph receptors.
Their complex interplay in space and time is responsible for proper cell migration.
Changes in Rho GTPase activity occur on the timescale of minutes, and their activities
are confined to sub-cellular regions. Numerous probes have been developed to examine
the spatial and temporal characteristics of Rho GTPases in a variety of processes, for
instance, the formation of cellular protrusions201. The next logical step is to examine how
the spatial and temporal characteristics of upstream regulators, such as the Eph receptors,
can affect these signaling patterns.
An optogenetic tool also opens the door for in vivo work. Many studies of Eph
receptors in vivo employed knockout models. While these studies are informative, Eph
receptors are RTKs that affect Ras/MAPK signaling and, therefore, expression of genes
involved in cell survival, proliferation, and differentiation. These effects may confound
experimental observations. Since Ephs and ephrins are so widely expressed and are
involved in crucial developmental processes, knockouts are often lethal. For instance, it
was reported that vascular problems in EphB2/B3 double-knockout mice caused a 30%
lethality rate69. Using an optogenetic tool permits targeted signal activation and, thus,
stimulation of a particular organ to achieve spatial specificity.

Novel insights into dendritic spine morphogenesis
Induction of actin branching suggests that EphB2 signaling can contribute to
spine head formation on filopodia, though new spines were not observed, possibly due to
the loss of extracellular domain-mediated interactions or the absence of a pre-synaptic
membrane that may contribute trans-cellular co-stimulatory signals that are also
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necessary for dendritic spine development. Prior data indicated the necessity of EphB
signaling in the development of dendritic spines14. We thus speculate that EphB2 activity
is necessary, but not sufficient, for the development of dendritic spines. Prior studies
showed increased spine density via treatment with pre-clustered ephrinB ligands15,
suggesting that EphB stimulation was sufficient for additional spine formation.
However, these spines may have formed at contacts with axons, a notion supported by
immunofluorescence assays that showed an increased density of co-localizing puncta
containing pre- and post-synaptic markers15. If these spines formed at axonal contacts, it
is likely that other cell-cell recognition molecules, and perhaps glutamatergic activity,
supplemented EphB signaling to complete spine formation. The ability of EphA4, which
is enriched at dendritic spines202, to bind ephrinBs23 also sheds doubt on the sufficiency
of EphB signaling alone to induce spines.
Since axons and dendrites can form local contacts on dendritic shafts, we
examined the effect of local EphB signaling on dendritic shafts as well and observed
formation of new filopodia-like protrusions.

An early study of EphB signaling in

dendritic spine morphogenesis described an increase in total protrusion density following
ephrinB1-Fc ligand treatment of cultured hippocampal neurons15.

It was, however,

unclear if EphB signaling induced the formation of new protrusions or served to stabilize
extant filopodia and spines. The latter case would strongly suggest a function for EphB
signaling in stabilizing filopodia upon contact with axons, a crucial initial step in
dendritic spine morphogenesis9. Our observations show spatially-restricted formation of
filopodia-like protrusions, suggesting that EphB signaling up-regulates spine density by
introducing additional putative synapses. Spatial restriction suggests that EphB signaling
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at axo-dendritic contacts may help neurons “hone” filopodia formation to dendritic
locations nearest axons. Future experiments may explore how spatial confinement of
filopodia formation is achieved.
The design of optoEphB2 may also explain the discrepancy between our
stimulation protocol and results of ligand-mediated stimulation.

Removal of the

extracellular domain was advantageous to reduce interactions with endogenous ephrins
and cis interactions with other receptors, but EphB2 was shown to interact with
NMDARs via its extracellular domain20. The Cry2olig-mCherry fusion at the receptor’s
C-terminus blocked the carboxy terminus of the PDZ-binding motif, which was shown to
scaffold EphB2 together with AMPARs through GRIP156.

Structural studies have

suggested that a free carboxy-terminus is necessary for PDZ binding, but this conclusion
is controversial186,203. Our data indicated that placing the PBM at the C-terminus of
optoEphB2 did not have a significant impact on filopodia formation in dendrites. Given
that isolated PBMs were shown to bind PDZ domains186, we suspect that moving the
PBM itself to the C-terminus of optoEphB2 would allow interactions with PDZ domains.
A C-terminal YFP fusion of EphB2 did not affect the normal kinase activity or regulation
of EphB2, and stimulation of NG108 cells overexpressing EphB2-GFP fusion caused the
expected retraction of neurites182. Additionally, overexpression of an EphB2-YFP fusion,
in which YFP was inserted N-terminal to the EphB2 PBM, rescued dendritic spine
morphogenesis in EphB1-B3 TKO neurons16,156.

This is similar to the design of

optoEphB2-PBM. I thus suspect that the placement of the PBM in optoEphB2 did not
significantly affect the validity of the experimental results, or the conclusions drawn from
them. However, these results can only be interpreted as showing the effects of EphB
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kinase activity on dendritic filopodia. Since previously-demonstrated interactions with
GEFs did not involve the PBM15,147,150, EphB kinase activity is likely the driving force in
spine morphogenesis and these caveats do not detract from the significance of the
findings.
Future studies may focus on how EphB2 recruits various synaptic proteins to
filopodia to affect the actin cytoskeleton. For example, the Shank family of scaffolding
proteins, which are enriched in spines, contain SAMs6 that may bind the SAM of EphB
receptors to affect filopodia.

Using the optogenetic tool to map the temporal

characteristics of actin and effector recruitment may permit differentiation between
effectors that are recruited to affect the actin cytoskeleton, and which effectors may then
be recruited by actin polymerization per se.

Spatial restriction may also permit

observation of differences between effects at filopodia, and effects on the dendritic shaft.
An increase in filopodia density was not observed with stimulation of filopodia
specifically, indicating that downstream signals were confined to filopodia, or that there
were differences in the signaling pathways initiated between the dendritic shafts and
filopodia. Studies on individual spines may also be performed to examine the effect of
Eph receptor signaling on dendritic spine plasticity.

Implications for understanding the cell context-dependence of EphB2 signaling
This thesis reports the first direct evidence of PI3K activation by EphB2 in
dendrites.

EphB signaling was previously shown to affect pain pathways and

Alzheimer’s Disease pathogenesis through PI3K99–101, though the localization of PI3K
activation remained unknown. Our observation of PI3K signaling by EphB2 in dendrites
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builds on the well-studied regulation of the Rho GTPases by EphB2 and the role of PI3K
in mediating Rho GTPase signaling. Our lab recently published a paper showing the
spatial regulation of Rac1 through PI3K activity174. Prior studies have shown that PIP3
can interact with the PH domains of the EphB2-interacting GEFs intersectin194 and
Tiam1193 and the sec14 domain of kalirin-7195,196. Thus, it is possible that EphB2mediated PIP3 synthesis may serve to spatially coordinate Rac1 and Cdc42 activation
near sites of axo-dendritic contact to drive dendritic spine morphogenesis, and future
experiments should address this question.

Additionally, PIP3 synthesis was well-

localized to the region of illumination, especially considering the rapid diffusion of
membrane lipids. The mechanism of such spatial restriction should be explored. Local
accumulation of PIP3 itself may be promoted, for instance, by the surrounding actin
dynamics, as demonstrated in chemotaxis187, or perhaps by rapid PIP3 dephosphorylation
or internalization. Use of an optogenetic tool, including EphB2, would be crucial to such
studies for spatial regulation of upstream signals. Such work could be extended to spatial
regulation in migratory cells to study, for example, how actin is spatially regulated to
achieve contact inhibition of locomotion.
Our results in MEFs and growth cones contradicted our observations of increased
protrusive activity and PI3K activation in dendrites. Observations of cell protrusion
collapse and changing growth cone morphology from lamellipodial to filopodial strongly
suggest collapse of dendritic actin networks.

However, broad plasma membrane

extensions were induced in filopodia, suggesting nucleation of dendritic actin networks.
In the case of hippocampal neurons, these diametrically opposed phenotypes were found
in the same cell type. Observing PIP3 accumulation in dendrites, with depletion in
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collapsing MEFs, suggests that Eph receptor-induced repulsion or adhesion depends, at
least in part, on up- or down-regulation of plasma membrane PIP3.
Further studies are therefore necessary to elucidate the neuronal pathways
between EphB2 and PI3K that result in activation or inhibition. Prior in vitro studies
indicated an interaction between phosphorylated EphB2 and the SH2 domain of p85 ( or
 not specified)50, which would result in PI3K activation. EphB2 may signal through Ras
in a cell context-dependent manner to activate or inhibit PI3K36. EphB2 is known to
inhibit Ras signaling through p120RasGAP in multiple contexts, though the SH2 adaptor
Grb2 was recruited to EphB signaling complexes in hippocampal dendrites17,72. Grb2
may activate PI3K through Ras by recruiting the Ras-GEF SOS, as shown in other cell
types downstream of EphB176. Grb2 may act independently of Ras by recruiting another
adaptor, Gab1, that can activate PI3K197. Our SH2 domain profiling, however, did not
detect binding of the SH2 domains of Grb2, p85α, p85β, or p55γ to phosphotyrosines
downstream of optoEphB2 (Fig. 2.3c). These SH2 domains did bind the positive controls
(Fig. 2.3c). Activation of PI3K via these pathways is, therefore, less likely. EphB2 was
also shown to form a complex with the Rac-GEF -Pix, Nck, and Pak, with PI3K activity
necessary to activate -Pix96. Although Nck did bind optoEphB2 in our assay, and is
known to bind EphBs50, this does not explain the activation of PI3K. It is also possible
that PI3K activation occurs through activation of Rac1 or Cdc42 as previously described
in other contexts37,174.
In addition to understanding the pathways themselves, central to Eph biology is
understanding the underlying mechanisms of cell context-dependence, and how that may
affect the pathways selected in different cell types. A study of EphB4 signaling to Ras
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supports the notion that differential expression of downstream effectors is responsible for
cell context-dependence79.

EphB4 inhibited proliferation in human umbilical vein

endothelial cells by down-regulating Ras through p120RasGAP, which was abrogated by
p120RasGAP knockdown. However, EphB4 increased cell growth in MCF7 cells by upregulating Ras activity in a manner that depended on the phosphatase PP2A. Other
studies suggest that the signaling background provided by other receptors may determine
the Eph receptor output. For instance, a study of cross-talk between EphB2 and FGFR
showed that EphB2 inhibited Ras when FGFR was activated, but activated Ras when
FGFR was not78. Feedback control of EphBs by the MAPK cascade was described as the
underlying mechanism.

EphB signaling inhibited chemotaxis in MTLn3 cells that

overexpressed EGFR98, which perhaps resulted in a Ras-activating background as well.
To determine the underlying biology in hippocampal neurons, it will be necessary
to examine the dendritic and axonal expression of potential EphB2 downstream targets.
Perhaps p120RasGAP is lacking in dendrites, but is expressed in axons, allowing EphBs
to up-regulate Ras through other adaptors and activate PI3K in dendrites.

Down-

regulation of Ras in growth cones by the typical mechanisms may explain growth cone
collapse. Functional assays would identify proteins that may reverse the functional
outcome of EphB2 signaling, discoveries that would mark a great advance in
understanding Eph receptor biology.
OptoEphB2 provides a functional module to approach these questions of cell
context-dependence, particularly in the case of polarized cell types. Neurons provide an
example, because protein expression and signaling activity can differ greatly between
axons and dendrites. However, migrating cells may also be polarized, especially during
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chemotaxis, with different signaling activities at the leading and lagging edges. Our data
and previous studies have shown that EphBs behave differently in the axonal and
dendritic compartments of hippocampal neurons. Activation of other RTKs, such as
FGFR, can influence the regulation of Ras/MAPK signaling by EphBs, through feedback
mechanisms in the Ras/MAPK pathway78. In Dictyostelium, spatial regulation of Ras and
PI3K signaling, with activation at the leading edge, has been demonstrated to guide
chemotaxis204,205, providing an example of how spatial regulation of proteins at the
cellular level affects cell migration. This raises the question of whether or not Eph
receptors differentially mediate adhesion or repulsion at the leading or lagging edges of
migrating cells.

Immunofluorescence can be used to detect spatially-regulated binding

between receptors and their effectors. However, optogenetics can be used to monitor
recruitment of effectors over space and time while simultaneously observing downstream
phenotypes. This advantage will allow future studies to probe the effects of Eph receptor
signaling in different cell compartments, which will expand our understanding of the role
that cell context plays in Eph receptor signaling outputs.

Conclusion
OptoEphB2 can be used for spatial and temporal control over an RTK that is
crucial to normal spine development and other developmental processes. This thesis
demonstrated the local morphologic effects of EphB2 signaling on the dendritic spine
precursors, dendritic filopodia, and suggested an important signaling pathway in
determining adhesion versus repulsion in response to EphB2 signaling.

These

observations improved the scientific understanding of EphB2 signaling in spine
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formation, and opened an array of new questions to continue exploring the molecular
mechanisms of the cell context-dependence of Eph receptor signaling.
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